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1 I.  INTRODUCTION 
The EU Member States and the  European Community have,  since the mid-1980s, 
adopted  important  common  measures  for  combating  drug  addiction  and  drug 
trafficking  and  for  promoting  international  co-operation.  These  multi-disciplinary 
measures come under various European Plans to combat drugs and action programmes 
approved by successive European Councils since 1990.
1 
The current EU Action Plan to Combat Drugs (1995-1999)
2  stresses the need for a 
global,  multidisciplinary and  integrated response based on the  following  four  key 
elements:  (i)  demand  reduction,  (ii)  supply  reduction  and  the  fight  against  illicit 
trafficking,  (iii)  international  co-operation  and  (iv)  co-ordination  at  national  and 
Union  level.  In proposing  the  current  Action  Plan,  the  Commission  at  this  time 
emphasised  that  effective  action  to  combat  drugs  required  a  comprehensive  and 
integrated approach. This did not mean that everyone must fight on all fronts and at all 
levels at the same time.  It meant that co-ordination and interaction of players and 
approaches must be ensured to reach maximum efficiency. 
The 1995-1999 Action Plan has been complemented by the report drawn up by the 
Group of Experts on Drugs approved by the Madrid European Council (December 
1995)
3
• 
The Treaty of Amsterdam has introduced the objective of providing citizens with a 
. high level of safety within "an area of freedom,  security and justice", three notions 
which are closely inter-linked. The fight against drugs is an inseparable objective of 
the area of  freedom, security and justice.  · 
The present communication is the Commission's follow-up to the Cardiff and Vienna 
European  Councils  conclusions  requesting  the  Council,  the  Commission  and  the 
European  Parliament  to  develop  into  a  comprehensive  plan the  post  1999  drugs 
strategy based on the key elements endorsed by the Cardiff European Council."  These 
key elements represent an effective basis for action at EU level. This communication 
also refers to the conclusions of the Vienna Council which invite the Member States 
and the Commission to study possible measures to intensify the fight against doping 
in sport. 
This communication also responds to a commitment taken by the Commission itself 
when adopting the current Action Plan (1995-1999) that it would submit a final report 
on the implementation of  the Action Plan. 
11be first European Plan to Combat Drugs was adopted by the Rome European Council (1990), 
followed in December 1992 by the adoption of  a revised and updated version by the Edinburgh 
European Council. 
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2 The EU Action Plan to Combat Drugs for  the period 2000-2004 is presented under 
Chapter Ill. The Plan covers the following areas: 
1.  Information 
2.  Action on demand reduction 
3.  Action on reduction of illicit trafficking in  narcotic .drugs  and psychotropic 
substances 
4.  Action at international level 
5.  Co-ordination 
The communication includes the following Annexes: 
-Towards an evaluation of existing EC and EU instruments and programmes (under 
ANNEX I); 
-Current trends in demand reduction (under ANNEX II); 
-Current development in legislation and practices (under ANNEX III); 
- 1998 Community funding in the field of  drugs (Table) (under ANNEX IV). 
3 II.  RECENT TRENDS IN CONSUMPTION AND TRAFFICKING IN THE 
EU 
At the level of  the European Union, effective and sound policies and strategies require 
the  availability  of objective,  reliable  and  comparable  information  on  the  drugs 
situation. This, in tum, requires common definition and concepts. For the purpose of 
this Communication, the tet:m illicit drugs refers to the substances listed in the three 
UN conventions from 1961, 1971  and 1988. As regards synthetic drugs, this term also 
covers new synthetic drugs put on the market and which are not yet listed in these 
conventions. 
The extent and magnitude of  the drugs phenomenon is now better known thanks to the 
valuable work carried out by the  European Monitoring Centre for  Drug and Drug 
Addiction (EMCDDA) and ~e  Europol Drugs Unit (EDU). The setting up of these 
two bodies  has given a new dimension to co-operation between Member States in the 
field of  information on the drugs situation in the EU. 
Based on information provided by the European Monitoring Centre for Drugs and 
Drug  Addiction  (EMCDDA)  in  its  1998  Annual  Report  and  by  EDU,  the  main 
features of  the drug situation in the EU can be described as follows: 
A.  Trends in illicit drugs use 
•  Cannabis is the most commonly used illicit drug across the EU, having been tried 
by between 1 and 8 % of the total population and up to 20% of younger adults. 
The use is stable on the whole. 
•  Amphetamine is the second most used illegal drug in most countries (tried by 2-
4% of  the adult population and up to  100/o of  young adults). Its use is continuing 
to rise and is likely to be more significant in the future than ecstasy. 
•  Ecstasy  use  is  no  longer  rising  in  those  Member  States  where  it  frequently 
appeared earlier but it is still rising in the others. 
•  Cocaine is modestly but steadily rising in use, although prevalence is still low. 
•  Crack remains a limited phenomenon. 
•  Heroin use appears relatively constant although there is some evidence of a new 
generation of  young heroin smokers. 
•  Other  substances:  solvents  are  often  the  second  most  abused  substances  by 
adolescents.  Misuse of medicines by adults  such  as  benzodiazepines,  often in 
combination with alcohol, is reported to be increasing. 
•  Drugs and health: the strongest link between illicit drug use and health damage is 
among injectors.  While rates of AIDS .have levelled out, the recorded cases of 
Hepatitis  may  have  serious  public  health  implications.  The  number  of drug-
4 related  deaths  is  generally  stable  or decreasing,  although  with  exceptions  in 
certain Member States. 
B.  Trends in lllicit drug production and traftkldng 
•  .  Most heroin seized in the EU originates from South West Asia. Central Asia is 
being increasingly used for the transit of  heroin coming from South West Asia to 
Russia or to the EU through the Balkan route.  In  Central  and Eastern  Europe 
heroin depots have been set up for further re-transportation of  the drugs to the EU, 
in  smaller  quantities.  Drug  trafficking  is  mostly  controlled  by  criminal 
organisations.  Turkish  criminal  groups,  and  also gradually  Albanian-Yugoslav 
criminal groups, play an important role in the heroin trade. Colombian heroin is 
partly destined for EU markets. 
•  Cocaine trafficking  towards  the  EU takes place predominantly by sea  freight. 
Colombia is the main producer of cocaine destined for the Member States. The 
Caribbean is one of the main areas of transit for cocaine trafficking to Europe. 
There is increased diversion of cocaine shipments to Central and Eastern Europe 
from where, subsequently, the drugs are transported overland to the EU. 
•  The EU is a major production region for synthetic drugs. Production of synthetic 
drugs in Central and Eastern Europe mainly affects the northern Member States. It 
poses a serious threat to the Member States, due to the lack of  precursors control 
in the region and the large availability of  professional chemists. 
•  Cannabis seizures in the Member States are massive,  up to 600 tons annually. 
Morocco is a major supplier of cannabis resin (hashish) to the Member States. 
Pakistan is another source country. Colombia, South Africa, Nigeria and Thailand 
are suppliers of herbal cannabis (marihuana).  Central  and  Eastern Europe is a 
transit  region  for  cannabis  destined  for  the  Member  States.  Cultivation  of 
cannabis,  for personal  use or distribution,  takes place nowadays in almost  all 
Member States, although there are no signs oflarge scale intra-EU trafficking. 
•  Substantial  reduction  in  illicit  coca  and  opium  poppy  cultivation  is  being 
achieved,  in  line with  the  commitm~ made by world  leaders  at  the  United 
Nations General  Assembly Special Session on Drugs (June  1998, New York). 
These  achievements  in  the  main  producing  countries  are  the  results  of the 
mobilisation  of  the  international  community  in  support  of  the  producing 
countries'  efforts to eliminate illicit cultivation through sustainable development 
which takes into account in particular measures related to alternative development 
and access to international trade markets. 
5 III.  THE EU ACTION PLAN TO COMBAT DRUGS (2000-2004) 
A.  The European Union approach: a global, multidisciplinary and integrated 
strategy to fight illicit drugs 
On the eve of the year 2000, the drugs problem continues to  pose threats and new 
challenges such as the growing success of synthetic drugs among young people and 
the  worrying  phenomenon  of the  increasing  number of juveniles,  sometimes  pre-
adolescents, involved with criminal groups in the sale of illicit drugs. Also, sporting 
activities  has  now  become  activities  which  can  lead  to  the  development  of new 
addictions. The social and health aspects of  the drugs problem, which poses threats to 
both the users themselves and to their families, are increasingly recognised in the EU 
Member  States.  The  relationship  between  drug  abuse  and  a  broader  social 
disadvantage, such as poverty, deprivation, unemployment, homelessness, exclusion 
as well as the links between drug abuse, delinquency and crime indicate the necessity 
to ensure a balanced approach between demand reduction and supply reduction. 
According  to  the  results  of the  first  Eurobarometer on  public  safetY,  illicit  drugs 
considerably affect the life of the citizen.  Actual contacts with open drug scenes -
seeing people openly dealing drugs or finding syringes in the park- as well as actual 
victimisation  by  violent  crime  are  important  sources  of feelings  of insecurity  in 
European cities. On average, fourteen percent of EU residents have been in contact 
with drug-related problems in their own area over the past 12 months. 
Since the beginning of  the nineties, drugs issues appear high on the political agenda of 
the European Union,  a situation which reflects the recognition that  fighting  against 
illicit drugs represents a common threat requiring an integrated approach to the drugs 
phenomenon and intense co-operation at all levels. 
The  international  dimension  of the  fight  against  drugs  is  widely  recognised  as 
requiring more intense co-operation.  Problems are common and the solutions must 
also be so. The progress achieved during the past few years is important in the sense 
that  agreement  has  been  achieved  on  some  fundamental  principles  concerning 
international drugs control co-operation. Whereas at the beginning of the 1990s this 
co-operation was dominated by a divide between producer and consumer countries as 
well as by a heavy emphasis on law enforcement, the emphasis has now shifted to a 
broad consensus between the developing world and the developed world, between so 
called 'producer' and 'consumer' countries. Drugs control is today recognised as part 
of overall efforts to foster social and economic development in a broader sense. The 
concepts of 'shared responsibility'  and  'partnership' have become the basis for co-
operation in this field. The drug problem is being viewed from a broader set of  human 
welfare  issues  addressing  the  social  and  economic  dimensions  of sustainable 
development in both producing and consuming countries. 
s Carried out by the Commission in view of  a joint EC/EP/Presidency seminar on the Prevention of 
Urban Delinquency linked to Drugs Dependence (Brussels, 21-22 November 1996) 
6 B.  Evaluation 
Evaluation must be an integral part of the EU  approach to fighting illicit drugs. The 
necessary methodological tools for the evaluation of  drugs policies and strategies are 
currently not sufficient and will need to be developed. Efforts carried out at EC level 
in the 1995-1999 period in the field of  evaluation have been insufficient and will have 
to be reinforced. Recourse at EC level to external independent experts for evaluation 
purposes will need to be widely used. A mid-term review of  the EU Action Plan will 
be conducted by the EC and presented to the Council and the Parliament. The regular 
assessment  of the  magnitude  and  nature  of drug  use  by the  EMCDDA  and  data 
produced by EDU on trafficking constitute valuable resources for the identification of 
any emerging trends and the improvement of  the knowledge at EU level on the drugs 
phenomenon. 
Evaluation is not to be achieved without difficulties. Evaluating the efficiency of the 
fight against illicit drugs abuse, production and trafficking poses the difficult question 
of  defining appropriate performance indicators. Also, some of  the EC and EU actions 
and programmes have been launched recently and have not yet been evaluated. 
Up to now the issue of evaluation has not been tackled as a priority issue. But this 
trend  is  changing.  Efforts  will  therefore  be  concentrated in  this  area  as  more  EC 
programmes will be evaluated by the EC through recourse to independent experts. For 
EU programmes, joint evaluation will be proposed. 
Evaluation has been the subject of  limited feasibility studies and small-scale studies in 
Europe carried out in particular by the  EMCDDA and the Pompidou Group of the 
Council  of Europe.  The  EMCDDA  is,  however,  focusing  its  scientific  work  on 
evaluation and has issued and will continue to issue guidelines for the evaluation of 
demand reduction activities and models for the assessment of  policies. 
It will be of  the utmost importance to concentrate efforts on the regular evaluation of 
achievement of the initiatives, programmes and policies initiated or pursued during 
the 2000-2004 period. In this context, and whenever possible, impact evaluation will 
be implemented. In particular, it will be essential to adapt existing evaluation means 
and  tools,  including  those  produced  by the  EMCDDA,  in  order  to  facilitate  the 
assessment  of the  level  of achievement  of objectives  described  in  the  present 
communication. 
Clearly more  attention  should be given  in  future  to  this  activity.  External  experts 
should be involved in the establishment of  the evaluation indicators and the evaluation 
process in itself.  Steps have been taken in this direction with the ongoing external 
evaluation  of the  Community  Action  Programme  on  the  Prevention  of Drug 
Dependence. A mid-term report will be transmitted to the Parliament and the Council 
during the first half of 1999. The main elements of  this evaluation are included under 
Chapter III Section F  .2.1. 
7 C.  New challen1es 
There is a need to improve the monitoring of the drugs problems to rapidly identify 
new challenges and adopt appropriate strategies 
The following new challenges have been identified: 
•  Cannabis,  amphetamine  and  ecstasy:  the  EU  is  a  major  production  and 
consuming  region  of these  three  illicit  drugs,  as  mentioned  under chapter n. 
Major efforts should continue to be pursued at EU level to fight their production 
and abuse. In particular, new challenges have arisen with the growing appeal of 
synthetic  drugs  (amphetamines  and  Ecstasy  type  stimulants)  among  young 
people. 
•  Urban  delinquency:  the  worrying  phenomenon of the  increasing  number of 
juveniles, sometimes pre-adolescents, involved with criminal groups in the sale of 
illicit  drugs
6  points  up  the  need  for  social  measures  to  prevent  the  onset of 
addictions  and/or  their  escalation  into  more  damaging,  i.e.  criminal  fonns. 
Comprehensive projects which combine a mixture of  different measures are most 
likely to  produce lasting results.  There is also  the need to collect drug-related 
crime statistics at EU level. . 
•  Other health, social and criminal justice challenps: these include polydrug 
use, hepatitis, social exclusion, community involvement in prevention, drug use in 
prisons, alternatives to punishment, social and _vocational reinsertion. 
•  Preparation for enlargement: 
Participation in the EMCDDA and in different drug related EC and EU 
Programmes 
The pre-accession strategy included the possibility for the candidate countries to 
become members of certain Agencies such as the EMCDDA, even before full 
membership  of the  Union.  In September  1998,  the  Commission  agreed  that 
maximum  participation  of the  11  applicant  countries  plus  Turkey  in these 
Agencies was desirable, with decisions to be made on a case-by-case basis. The 
Commission  intends  to  present  a  draft  negotiating  mandate  for  all  applicant 
countries  in  view  of their  participation  in  the  EMCDDA  through  bilateral 
negotiation with each of  them which fonnally requests it. Pre-accession strategy 
also  covers  the  participation  of  the  candidate  countries  in  Community 
programmes such as those in the public health field. The Community programme 
on prevention of  drug dependence was opened for the participation of  Hungary in 
1998. Other candidate countries are expected to join in 1999. Concerning the co-
operation programmes under Title VI of  the TEU (Justice and Home Affairs), the 
Commission is envisaging to amend the existing legal basis of  these programmes 
to make possible the full participation of  the applicant countries. 
6 Joint ECIEP/Presidency seminar on the prevention of  urban delinquency linked to drugs dependence 
(Brussels, 21-22.11.96) 
8 (2) 
The Phare Multi-Beneficiary Drugs Programme 
The Multi-Beneficiary Drugs Programme is the main Phare supported programme 
to develop the institutional capacity of  the ten candidate countries of  Central and 
Eastern Europe to develop multi-disciplinary and co-ordinated drug policies, in 
line with the EU drugs strategy. The programme also provides for the integration 
of non-candidate countries namely Albania, Bosnia-Herzegovina and the Former 
Yugoslav Republic of  Macedonia. 
The  Programme  is  organised  around  three  pnontles:  ( 1)  drug  information 
systems,  (2)  drug  supply  reduction,  and  (3)  drug  demand  reduction,  where 
emphasis is put on capacity building for the development of  integrated prevention 
programmes, including the active involvement of  the civil society. Following the 
extension of  Phare assistance to the field of  Justice and Home Affairs, emphasis 
is also given to drug law enforcement. 
To  facilitate  the  transposition  of the  EU  acquis  in  the  field  of drugs,  the 
Programme is focusing on support for institution building in order to establish the 
required legislation and  standards and to  reinforce the operational capacities of 
the drug control structures. 
D.  The new legal framework provided by the Treaty of  Amsterdam 
Further  to  the  Maastricht  Treaty  on  European  Union  which  extended  the 
Community's  scope  for  action  in  the  field  of drugs  as  well  as  the  scope  for  co-
operation  between  the  EU  Member  States,  the  entry  into  force  of the  Treaty  of 
Amsterdam will represent a new step forward in the fight against drugs in the field of 
public health by the possibility of introducing prevention measures (Article  152) in 
the  law  enforcement  area by the setting up  of reinforced co-operation in  the  fight 
against illicit drug trafficking (Title VI) and in the field of  international co-operation. 
(i) Drugs, a Public Health priority (Title XIII, Article 152 of  the EC Treaty) 
Article I 52 (1) first paragraph of the EC  Treaty indicates that A high level of  human 
health  protection  shall  be  ensured  in  the  definition  and  implementation  of all 
Community policies and activities.  This implies the mainstreaming of public health 
priorities in all  Community policies and  activities,  like the youth programmes, the 
research programmes, the programmes and activities in the social field. 
Article  152  (1)  second  paragraph  stipulates  that  Community  action,  which  shall 
complement  national policies,  shall be  directed  towards  improving public health, 
preventing human  illness and diseases,  and obviating sources of danger to  human 
health.  Such  action  shall  cover  the fight  against  the  major  health  scourges,  by 
promoting research into their causes, their transmission and their prevention, as well 
as health  information  and education.  The Treaty no  longer singles out drugs as  a 
major scourge but clearly drugs remains a priority subject for Community action in 
the field of public health. Indeed, Article  152 (1) third paragraph mentions that The 
Community shall complement the Member States' actions in  reducing drugs-related 
health damage,  including information and prevention.  The reduction of drug-related 
9 health damage appears as a new objective of  the co-operation between Member States, 
alongside the traditional co-operation in the prevention field. 
Article 152 (3) stipulates that The Community and the Member States shall foster co-
operation with  third countries and the competent international organisations in  the 
sphere of  public health.  Article 152 (  4) indicates that the Council can adopt, on the 
basis of Article  251  of the  EC  Treaty (co-decision procedure),  incentive measures 
designed to protect and improve human health,  excluding any harmonisation of  the 
laws and regulations of  the Member States. 
The new provisions of Article  152  will need to  be exploited to the  full  in order to 
enhance co-operation in the area of  demand reduction and achieve, whenever possible, 
an  approximation of practices in areas  such as evaluation methods and procedures. 
Exchange of information on "best practices" in  drug prevention and  in  other areas 
such  as  the  alternative  measures  to  penal  sanctions  should  be  encouraged.  At EU 
level, the current achievements of the Drug Dependence Programme will need to be 
considered as a basis for further progress in bringing closer the practices in demand 
reduction and prevention 
(ii)  Drugs,  a  priority  for  co-operation  in  the  field  of Justice  and Home  Affairs 
(Title VI o[the Treaty on European Union- TEU) 
The new legal framework puts the co-operation between the EU Member States in the 
fight  against  illicit  trafficking  into  a  new  institutional  framework  which creates  a 
Treaty  obligation  of working  together  on  the  basis  of a  spirit  of dialogue  and 
conciliation between different approaches pursued by the Member States. 
The main innovation of  the Amsterdam Treaty is the objective stipulated in Article 29 
(ex-K.l) to police and judicial co-operation which is to provide citizens with a high 
level of safety within "an area of freedom, security and justice". This objective must 
be achieved by preventing and combating crime at the appropriate level," organised or 
otherwise,  in particular  ...  illicit drug  trafficking".  Three methods  are envisaged to 
fight against illicit drug trafficking: 
- closer co-operation between police forces, customs authorities and other competent 
authorities, directly or through Europol; 
- closer co-operation between judicial and other competent authorities of the Member 
States; 
-approximation, where necessary, of  rules on criminal matters in the Member States. 
Under Article 34 (ex-K.6) the Commission now has a shared right of initiative with 
the Member States in all the areas referred to in Title VI. The legal decisions adopted 
by the Council will continue to be based on the unanimity rule. In addition to common 
positions and conventions, two new instruments have been introduced: 
- the  framework  decision (binding but leaving to  national authorities the choice of 
forms  and  methods  to  achieve  the  result)  for  the  approximation  of the  laws  and 
regulations of  the Member States; 
10 - the decision (binding with no direct legal effect) for any other purpose consistent 
with  the  objectives  of Title  VI,  excluding  any  approximation  of the  laws  and 
regulations of  the Member States. 
Furthermore  the  Treaty  fixes  a  number of objectives  for  police  and judicial  co-
operation,  which are  tracks  to be explored  with the  aim  of intensifying  the  fight 
against drugs. 
It is  within  this  framework  and  with  the  support  of both  Europol,  which  has  a 
particular role  in the  Amsterdam  architecture  of support  and  co-ordination  in the 
implementation of the co-operation of law  enforcement services (art.30.2),  and the 
EMCDDA, that the Council will have, pursuant to Amsterdam, to take the measures 
and favour the co-operation with the purpose of  contributing to meeting the Union's 
objectives (art. 34) by deciding by unanimity, and this following the initiative of any 
Member State or the Commission. 
Article 31  (e) foresees the adoption of  measures establishing minimum rules relating 
to the constituent elements of  criminal acts and to penalties in the fields of organised 
crime, terrorism and illicit drug trafficking. Under a Declaration on this Article, it is 
said that these provisions shall not have the consequence of  obliging a Member State 
whose legal system does not provide for minimlim sentences to adopt them. 
The role of  the Court of  Justice is reinforced by Article 35 (ex-K.7) as the Court will 
have jurisdiction to  give  preliminary rulings  on the  validity  and  interpretation  of 
decisions  taken  under  Title  VI.  But this  control  is  subject  to  the  declaration  of 
competence by the Member States (paragraph 2). Moreover, the Court shall have no 
jurisdiction to review the validity or proportionality of operations carried out by the 
police or other law enforcement services. The role of  the European Parliament is also 
reinforced under Article 39 (ex-K.ll) as it will have to provide its opinion before the 
adoption  of framework  decisions,  decisions  and  conventions,  instead  of being 
consulted only on the principal activities under Title VI. 
The possibility of  establishing closer co-operation between Member States is foreseen 
under Article 40 of Title VI as long as the co-operation proposed  (a) respects the 
powers of the European Community and the objectives laid down by Title VI and (b) 
has the aim of enabling the Union to develop more rapidly into an area of freedom, 
security and justice. Under these conditions, the Council can authorise the setting up 
of closer co-operation, acting on a qualified majority at the request of the Member 
States concerned and after inviting the Commission to present its opinion. But if a 
Member State declares that,  for important and stated reasons of national policy, it 
intends to oppose the granting of  an authorisation by a qualified majority, a vote shall 
not be taken. 
The integration of  the Schengen acquis into the .framework of  the European Union is 
foreseen through a Protocol annexed to the Treaty. This is a fundamental change to 
the scope of this co-operation.  With the new operational powers given to Europol 
(Article 30 paragraph 2),  co-operation will be more concrete and will give a  new 
impetus to the efforts being made in the fight against illicit drugs. 
11 (iii) Drugs. a priority for  international co-operation 
The Amsterdam Treaty does not provide new instruments other than those  already 
existing under the previous Treaty, that is to say common positions and joint actions 
mentioned respectively under Articles 14 and  15 of the TEU (former Articles 1.4 and 
J.S).  The EU has recognised the importance of the drugs issue in foreign policy by 
applying two broad categories of action: (i) multilateral action through active support 
for  global  policy-making,  strengthening of strategy-setting by UN  institutions  and 
effective  functioning  of informal bodies.;  (ii) bilateral  and  regional  actions mainly 
through  three  types  of instruments  for  co-operation  with  third  countries  in  the 
framework  of drugs  clauses  introduced  in  EU  agreements  with  third  countries: 
political dialogue, trade policy and financial technical support. 
E.  Main aims and objectives 
In line with the principle of subsidiarity, the five general aims and objectives of the 
EU Action Plan 2000-2004 are the following: 
•  To ensure that the issue of the fight  against drugs is kept as a major priority for 
EU internal and external action; 
•  To continue the EU integrated and balanced approach of  the fight against drugs, in 
which supply and demand reduction are seen as mutually reinforcing elements; 
•  To  ensure  collection,  analysis  and  dissemination  of objective,  reliable  and 
comparable  data  on  the  drugs  phenomenon  in  the  EU  with  the  support  of 
EMCDDA and Europol; 
•  To  promote  international  co-operation,  integration  of drug  control  into  EU 
development co-operation and to support the efforts of  the United Nations and of 
UNDCP  in  particular  to  develop  international  co-operation,  based  on · the 
principles adopted at UNGASS; 
•  To  emphasise  that,  while  not  bidding  for  new  resources,  the  successful 
implementation of the strategy and  actions mentioned  in  this  Action Plan will 
necessitate appropriate resources. 
The major characteristics of  this Plan are the following: 
•  it emphasises the need for evaluating the experiences made and identifying the 
best  practices  with  a  view  to  ensuring  the  consistency  and  continuity of the 
Community action in tackling the drugs phenomenon; it, thus,  builds upon the 
previous Action· Plan;  · 
•  it identifies new challenges and strategies to be implemented at EU level and in 
co-operation with our international partners; 
•  it  reaffirms  our  commitment  to  the  UN  Conventions  on  drug  control,  in 
accordance with the EP resolutiQJJ. of  October 1998
7 
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12 F.  Specific targets 
The specific targets ofthe Action Plan in the five domains of  action are the following: 
1.  Information 
The EU global strategy to combat drugs has to be based on a regular assessment of 
the nature and magnitude of drug use in the population and its consequences, as 
well as on knowledge acquired from  research and on lessons derived from past 
programmes. 
It is the task of the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA)  to  collect,  analyse  and  compare  existing  data  on  the  drugs 
phenomenon. It is of the utmost importance to ensure that the highest quality of 
information flows to it. In particular, improving comparability of data is a central 
task of the  EMCDDA.  The REITOX national  focal  points will have to play a 
central  role  in  this  context.  Progressive  harmonisation  of key  epidemiological 
indicators on the prevalence and health consequences of  drug use
8 is needed. This 
is an important challenge since, in particular, structures for collecting data on each 
indicator differ between Member States. National authorities should reinforce their 
commitment to this challenge with political and institutional support. This task will 
not be achieved quickly nor easily. Improved comparability of  statistics should also 
be accompanied by measures to ensure quality (including training) and to interpret 
and understand the data in national and local contexts. 
The  EMCDDA,  in  close  co-operation  with  its  REITOX  national  focal  point 
network, will pursue and concentrate its efforts on: 
the regular collection, analysis and dissemination of  data at European level 
concerning drugs and drug addiction and their consequences'; 
the improvement of  data comparison methods: 
the implementation of  common indicators among Member States 
the systematic and scientific evaluation of  demand reduction activities, 
including cost-effectiveness 
the co-operation with European and international bodies and organisations and 
with non-Community countries. 
By the year 2004, the EMCDDA will progressively cover all areas specified in the 
regulation establishing the Observatory: 
demand and reduction of  the demand for drugs; 
national and Community strategies and policies; 
international co-operation and the geopolitics of  supply (with special emphasis 
on  co-operation  programmes  and  information  on  producer  and  transit 
countries); 
1 The five key indicators concern: the demand for treatment by drug users; drug-related deaths, 
mortality and .:;auses of  death among drug users; the incidence of  drug-related infectious disease (HIV, 
hepatitis B and C); the comparability of  surveys of  drug use, behaviour and attitudes in general 
population; and the comparability of  prevalence estimates of  problem drug use. 
13 control of the trade in narcotic drugs, psychotropic substances and precursors, 
as provided for in the relevant present or future international conventions and 
Community acts; and 
implications  of the  drugs  phenomenon  for  producer,' consumer  and  transit 
countries, including money laundering, as laid down by the relevant present or 
future Community acts. 
In the framework  of the  Statistical Programme  1998-2002, Eurostat, the  Statistical 
Office of the European Communities, and the EMCDDA will co-operate closely in the 
development  of  definitions  and  other  methods  aimed  at  providing  comparable 
statistical information at Community level. For data collection on drug-related deaths 
and data through  health-related surveys the EMCDDA is  already co-operating with 
Eurostat. 
2.  Action on demand reduction 
The  highest  priority  should  be  given  to  health,  education,  research  and  training 
activities and on instruments to combat social exclusion. Exchanges of experience and 
best practices on demand reduction and promotion of networks at city level  and of 
professionals should be supported.  Adequate resources should be available for these 
types of activities. 
Given comparable methods for surveys and data collection at Community level, two 
major objectives have been set for the EU and should be evaluated before 2004: 
(i) to reduce significantly over 5 years the prevalence of illicit drug use among young 
people under 18 years of age; 
(ii) to reduce substantially over 5 years the number of  ~g-related  deaths. 
2.1.  Public Health 
The key problems in this area are the following: 
•  The rise in the demand for drugs especially among young people; 
•  The increase in  oral use of illicit drugs, such as  "ecstasy", new  synthetic drugs 
and smoking heroin; 
•  The growing problem of the abuse of amphetamine in particular ; 
•  The frequent underrating of relevant health risks; 
•  The  high  prevalence  of hepatitis  C  and  :mv  I  AIDS  as  well  as  other  serious 
diseases among intravenous users; 
•  The high number of drug-related deaths in many Member States. 
Consideration of the following main challenges will need to be taken into account: 
•  To  identify  best  practices  on  prevention  for  further  use,  and  to  ensure  peer 
influences and support in preventive tools designed for the target group; 
•  The  necessity  for  a  comprehensive  preventive  approach  in  schools,  in  co-
operation  with  the  whole  school  community,  including  specific  training  of 
teachers in early recognition of young peoples problems; 
14 •  The need to put a greater emphasis on instruments to combat social exclusion, in 
order to  prevent drug abuse and to  help  with the re-integration of former drug 
users; 
•  The health and social aspects linked to the mobility of  risk groups in and towards 
the  EU  Member  States,  migrants  and  displaced  people,  and  those  problems 
caused by drug tourism; 
•  Improving the  quality of substitute treatment programmes with oral methadone 
and further exploration of  alternative less addictive substitutes. 
•  The necessity to  balance a number of considerations such as  law  enforcement 
goals and the treatment needs of the drug users, and further implementation of 
alternative measures to imprisonment. 
Future orientations in the field of  public health aspects should take into account: 
(i) the need to rank very high the imperatives of public health as the basis for action 
and to complement specific public health instruments with other relevant Community 
policies and activities. There is also a need for adequate funding for the specific public 
health instruments; 
(ii)  experience  gained  to  date  in  the  implementation  of the  Community  Action 
Programme on the Prevention of Drug Dependence and other relevant public health 
programmes (Aids prevention and health promotion); 
(iii)  integration  with  the  forthcoming  plan  for  public  health  policy  with  its  three 
strands  of action:  improving  information  for  the  development  of public  health; 
reacting  rapidly  to  health  threats;  tackling  health  determinants  through  health 
promotion and disease prevention;
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(iv) the guiding principles on drug demand reduction adopted by UNGASS in June 
1998 which foresees the setting up of a comprehensive demand reduction strategy and 
puts unprecedented emphasis on demand reduction as part of an integrated approach 
to the drug problem. 
Resulting  from  the  mid-term  evaluation  of  the  1996-2000  Drugs  Prevention 
Programme,  the  following  recommendations  for  future  action  in  the  framework  of 
drug prevention can be made: 
•  To consider further studies and pilot projects on: (i) early identification of  changed 
drug-use  trends,  either  of already  known  substances  or  new  substances  and 
(ii) evaluation of the  impact of prevention actions:  do  interventions  reach  their 
targets? What is the impact on single individuals/on groups/at Community level? 
•  To  improve liaison between the  projects and  activities of relevant international 
agencies. To stimulate international co-operation between national public bodies 
as a way to enhance the growth of  shared perceptions of  events. 
9 COM (98) 239 fmal of 15.04.98 
15 •  To  adopt  a  more  pro-active  approach  for  the  prevention  and  reduction  of 
associated health risks, which should be grounded on a comprehensive strategy 
that can be used to drive the cost-effective allocation of  resources. 
•  To  further  develop  pilot  studies  of target  groups  in  the  framework  of the 
prevention and reduction of associated risks, given the geographical spread and 
the social and cultural diversity of  the Member States. Such studies should be fully 
grounded in a wide-ranging context that allows comparisons through all or at least 
most of  the Member States. 
•  To develop prevention projects in the area of  information and educational tools for 
target  groups  taking  into  account  the  Evaluation  Guidelines  for  Prevention 
Projects,  prepared  by the  EMCDDA.  The project  results  should  be presented 
accordingly. 
•  To  continue  subsidising  the  functioning  of networks  aimed  at  community 
exchanges  concerning  local  prevention.  These  networks,  while  taking  due 
consideration  of national  policy  requirements,  follow  the  goal  of developing 
municipal drug policy strategies in collaboration with other cities in the Member 
States. The target would then be to strive for ·co-operation between the current 
comparable networks,  and  in  so-doing,  perhaps  achieve  new  complementarity 
effects. 
•  To develop  training programmes related to the prevention of drug dependence 
aimed  at developing  more  intensively:  (i)  innovative training  strategies which 
facilitate coping with new challenges and (ii) integration mechanisms that would 
ensure community-based training. 
A comprehensive approach is still considered to be the best strategy to meet future 
problems. Such an approach should cover all areas of drug abuse prevention, from 
discouraging the initial use to reducing the negative health and social consequences of 
drug abuse.  Community based prevention programmes and peer education projects 
should be implemented on a wider scale in the Member States. 
In a comprehensive approach all types of  drugs used and abused should be of  concern, 
licit or illicit. Risks for health damage are not limited to prohibited drugs. Many of  the 
new synthetic drugs are not yet controlled in the Member States. These are substances 
similar to and with more or less the same potential health risks as those which are 
controlled and prohibited.  · 
More attention should be paid to the connection between an early start with smoking 
tobacco, an early introduction to alcohol and initial use of illegal drugs. Tobacco and 
alcohol  are  themselves  without  any  doubt  drugs  proven  to  cause  severe  health 
damage. As such, preventive strategies implemented on tobacco and alcohol could 
also have impact on preventing initial use of  illegal drugs. 
One key issue should be an emphasis on helping drug users to reduce their existing 
drug demand. Reducing the adverse health and social  consequences of drug abuse 
should also be pursued. The availability of  a wide range of  treatment services of  high 
quality, both in-patient and out-patient is also of importance in a demand reduction 
16 perspective.  There  is  a  particular  need  for  further  development  of low  threshold 
services and to improve health care in prison. 
Taking into account that illegal use of  drugs in general is still rising, and this in spite 
of  all efforts made, more attention should therefore be given in the Member States to 
setting concrete standards for prevention programmes both in number and quality, for 
an easy access to treatment on all levels, as well as for measures to prevent relapses. 
2.2.  Education and raising awareness through information campaigns 
The  objective  is  to  provide  education  and  awareness  raising  which  could  play  a 
relevant role in the prevention of drug addiction and risk reduction. These activities 
should  (i)  improve  knowledge  about  drug  dependence  by  producing  and  using 
educational materials and methodologies and (ii) enable people to adopt a responsible 
attitude in front of  drugs. 
Educating young people and their parents about the nature and dangers of  drug abuse 
is a vital element in tackling the problem. Children need to be made aware of drugs 
from primary school level onwards. It is also important that parents and teachers are 
given  the  opportunity to  learn  more  about  drugs  so  that they can notice  and  help 
anyone with a possible drug problem. 
National  school  programmes  are  a  major  primary  prevention  measure.  Education 
programmes at national and European level have been initiated to establish protective 
factors  against  drug  abuse  by  developing  personal  and  social  skills  in  handling 
conflict situations and peer pressure and by  fostering critical attitudes and  decision 
making skills.  These kinds of approaches have also  been successfully applied as  a 
means of  incorporating primary prevention in leisure time activities. 
Mass media campaigns have been widely used as  a means of raising awareness on 
drug issues. To be effective, the messages in these campaigns should be well targeted, 
informed and realistic. It is of  the utmost importance that such information campaigns 
act  as  a supportive element  for  local  level  actions  undertaken with an  educational 
perspective, both for  young people  and  for  key persons  in  their environment.  The 
European Drug Prevention Week in  1998 is  a good example of combination with a 
European campaign to highlight the theme of  the week and to support the visibility of 
local events. 
The main priorities for education and awareness raising in Europe are the following: 
-The necessity for a comprehensive preventive approach in schools, in co-operation 
with the whole  school  community,  including  specific  training of teachers  in  early 
recognition  of young  peoples  problem.  The  comprehensive  approach  should  also 
include the families. 
- The  need  for  including  and  improving  drug  related  trammg  in  postgraduate 
education for professionals who will have their future work in the health-, social- and 
law enforcement sectors. 
17 - The development of flexible educational tools and methodologies for assisting the 
implementation and evaluation of  prevention programmes. Full use should be made of 
the experience and knowledge of  the EMCDDA in this field. 
- The  effective  utilisation  of new  media,  especially  the  Internet,  m  designing, 
implementing and evaluating educational prevention programmes. 
- The importance of peer groups has been widely recognised.  Most often, the first 
experimental  drug  use  occurs  because someone you  know  offers  you  drugs.  Peer 
groups  can  also  act  as  a  protective  factor.  Young  people  themselves  should  be 
involved, from  the beginning, in the setting up of prevention programmes. When a 
programme is targeted at the drug using population, the involvement of fonner drug 
users may be advisable. 
- The  active  participation  in  sports  and  other  hobbies  must  be encouraged.  It is 
especially important that  schools,  together with NGOs,  youth  clubs  etc  ... ,  arrange 
supervised activities during after school hours to offer attractive alternatives to  the 
youth. 
2.3.  Research 
The objective at EU level is to stimulate research to prevent and control drug-related 
health  problems  by  using  to  the  full  the  possibilities  that  exist  under  the  Fifth 
Framework  Programme  for  Research,  Technological  Development  and 
Demonstration.  Considering  the  limited  proportion  of  the  Fifth  Framework 
Programme budget with respect to the overall public spending for research in the EU, 
other relevant initiatives, in particular those undertaken at national level or in other 
European  fora,  should  be  given  appropriate  attention  in  the  realisation  of the 
objectives of  this action plan. 
The  Fifth  Framework  Programme  of the  European  Community  for  Research, 
technological  development  and  demonstration  activities  (1998  to  2002)
10  has 
introduced a specific priority for research activities related to the  figh~ against drugs 
with a view to prevent and, where appropriate, control drug-related health problems 
through  (i)  establishing  the  psychological  and  socio-economic  factors  involved  in 
drug-taking and  drug  abuse,  {ii)  developing  better understanding of the  long-tenn 
health and social consequences of  abuse, and (iii) developing more effective treatment 
strategies. 
The research priorities as mentioned in the work programme of  the th~e  "Quality of 
life and management. of  living resources" under the action line "Public health and 
health service research" are: 
- Biomedical approaches to drug demand reduction and treatment, including research 
into  rehabilitation  and  non-structured  bio-medical  support  (morbidity/mortality 
studies, treatment outcome, co-morbidity, behaviour and disease, multi-drug abuse, 
risk groups); 
10 Decision N° 182/1999/EC of  the European Parliament and of  the Council of22.12.98 0  J N° L 26 
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18 - Health and socio-economic aspects of  drug use and drug addiction (youth and other 
high risk or vulnerable groups, drug-use patterns, social effects,  economic costs of 
drug  use  and  addiction,  drug  related  health  services  research,  prevention, 
environmental determinants and public perception); 
- Physical detection, drug ·profiling and biological monitoring of  drugs, precursors and 
solvents. 
The action line "Neuroscience" also under "Quality of life and management of living 
resources"  will  specifically  look  into  understanding  reward  and  punishment 
mechanisms and their implications for learning and drug dependence. 
In addition, within the theme "Competitive and sustainable growth", attention is given 
to  measurements  and  testing  and  anti-fraud  methodologies.  This  activity  should 
enable illegally used substances or component, forbidden drugs in sports, illegal drugs 
trafficking and illegal (animal) trading to be detected. 
In  general,  attention  will  be  paid  to  the  socio-economic  impact  of the  drugs 
phenomenon. This will be developed in close co-operation with the EMCDDA, which 
develops  pilot  studies  in this  field.  In this  context,  a  project  co-ordinated  by the 
EMCDDA was selected during the third call  for proposals of the  Targeted Socio-
Economic Research programme. The project is entitled "European network to develop 
policy  models  and  socio-economic  analyses  of  drug  use,  consequences  and 
interventions. 
2.4.  Other key drugs related issues 
-Drugs and driving 
The objectives at EC level are: 
- to review the situation as far as drugs and driving is concerned; 
- to analyse the implication of illicit drugs in road accidents on the basis of available 
data; 
- to recommend more reliable methodologies for the collection of  such data; 
- to review and support development regarding road-side testing methods and .  further 
laboratory analysis, and their limitations; 
- to  review and further develop experimental control studies on driving impairment 
and pharmacocinetics; 
- to review and compare the measures taken in the field of  rehabilitation. 
Although the effect of alcohol on driving is well established, as is its role in traffic 
accidents,  there is  far  less  evidence of this  kind  for  other drugs.  There  is  still  an 
insufficient scientific basis to develop specific measures for drugs. This issue was not 
considered  under  the  1995-1999  Action  Plan  to  combat  drugs.  However,  it  was 
included in the first Action Programme on Road Safety adopted by the Commission in 
1993
11
,  following  which a  Working  Party on "Alcohol, Drugs and  Medicines  and 
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19 Driving" was established in early 1994 in the framework of  the High Level Group on 
Road Safety. 
This Working Party produced a report including a first set of recommendations such 
as  that  the  first  priority  was  to  define  the  true  nature  of the  problem  through 
epidemiological  research.  Its  recommendations  related  to  (i)  how  to  define  the 
prevalence of  illicit drugs among the driving population and the relative risks of  traffic 
accident involvement for the users of various drugs, individually and in combination, 
(ii) the combined use of  illicit drugs and alcohol and (iii) legislation for controlling the 
presence of  illicit drugs in drivers. 
More recently, the 1994 Working Party has been reactivated. The topic is maintained 
under the second Action Programme on Road Safety, adopted by the Commission in 
April  1997
12
,  covering  the  period  1997-2001  with  special  emphasis  on  the 
development of road checks. Appropriate co-ordination with the EMCDDA and the 
Pompidou Group  of the  Council  of Europe  has  been  established.  Under the  Fifth 
Framework Research and Technological Development Programme, research activities 
will  continue  on  issues  linked  to  driving  under  the  influence  of illicit  drugs  and 
prescribed medicines. 
- Doping in sport 
At  Community level,  the  following goals have been set for the next  five  years:  (i) 
improving information about doping and its consequences for the public at large; (ii) 
raising awareness of the problem among doctors; (iii) introducing and improving co-
ordination in the legislative field; (iv) establishing clear definitions, lists of forbidden 
substances and standards for testing; and  (v) improving health protection for  young 
athletes. 
So serious has been the increase in doping in  sport in recent years that the  Vienna 
European Council  underlined  its  concern  at  the  seriousness of the  problem  which 
undermines  the  sporting  ethic  and  endangers  public  health.  Professional  sport  is 
currently witnessing  the  development  of ever more  sophisticated  doping  methods. 
Many ordinary people for whom sport is a way of improving their quality of life can 
be exposed to drugs through sport. Doping in sport often does not mean taking illegal 
substances but misusing legal drugs. 
The problem of doping in sport requires a double approach. Doping at professional 
level should be treated as a professional matter. Indeed, rules against doping require 
close  co-ordination  between  States,  sporting  organisations  and  international 
organisations. Eliminating doping at amateur level calls for more uniform measures 
already tested in the general fight against drugs.  It is  important to bear in mind the 
impact of sporting activities on the general public and the influence of sports stars' 
behaviour on young people. Combating drugs in sport is therefore an excellent means 
of  getting the message across in the more general fight against drugs. 
The Member States and the Commission agreed on the need to develop new measll!es 
at Community level to make more effective use of the different Community policies 
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20 and to hannonise legislation. As trafficking in illicit substances can also be involved 
in doping in sport, the framework of  the co-operation in justice and home affairs could 
also have a role to play in this respect. 
Finally, the fight against doping in sport calls for closer international co-operation. 
Athletes  are  becoming  increasingly  mobile  and  need  a  clear  and  precise  legal 
framework to avoid committing an offence. 
3.  Action on  reduction  of  illicit trafficking in  narcotic drugs  and psychotropic 
substances 
Priority attention should be given by the EU to enhancing measures and instruments 
related to (i) the control of chemical precursors diversion within the EU and in third 
countries, (ii) the prevention and the fight against money laundering, (iii) the effective 
co-operation between police, customs and judicial authorities, (iv) the implementation 
of the  EU Action Plan on Organised Crime,  (v) the prevention of the use of new 
communication systems (e.g. Internet) as means of  developing drug abuse, production 
and  trafficking,  (vi)  the  international co-operation in the  fight  against  illicit drugs 
trafficking. Co-ordination and co-operation represent key elements for the successful 
implementation of  these policies. 
3.1.  Consolidation of the acquis communautaire 
3  .1.1.  Diversion of  precursors and psychotropic substances 
Precursors are an important area of  the supply reduction side of the drug problem as 
they  are  essential  chemicals  indispensable  for  the  manufacture  of drugs;  these 
chemicals are commonly traded and used for the manufacture of  licit products such as 
plastics or phannaceuticals; however, a small part of them is diverted to the illicit 
manufacture of  drugs, namely heroine, cocaine and synthetic drugs. 
More specifically, precursors are any of the 22 scheduled chemical substances which 
are listed in Table I or II of the United Nations Convention against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances of 1988 (UN 1988 Convention) of  which 
the  Community  is  a  Contracting  Party under its  Article  12  alone  that  deals  with 
precursors.  Monitoring  external  trade  on  precursors  is  a  Community  competence 
under Article 113 ofthe EC Treaty. 
The Community has approved the appropriate internal legislation to fight precursor 
diversion  at  Community  and  international  level.  While  Council  Directive 
92/109/EEC
13  deals  with  the  manufacture  and  placing  of precursors  on  the 
Community market, Council Regulation 3677/90
14  addresses the trade in precursors 
13 OJ n° 370 of 19.12.92. The Annexes to this Directive were modified by Commission Directive 
93/46.EEC of  22.06.93. 
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21 between  the  Community  and  third  countries  by setting  forth  a  number  of export 
requirements. 
The  existing  Community  precursor  control  system  has  worked  correctly.  Further 
improvement  are  envisaged  through  (i) enhanced  co-operation  with  industry  and 
(ii) the conclusion of  precursor control agreements with more risk countries which are 
capable of  coping with the monitoring mechanisms under those agreements. 
As precursor diversion is the exception to licit commercial transactions, a purely law 
enforcement  approach  on  precursor  control  is  not  rewarding.  Efforts  to  counter 
diversion have to be balanced with the needs of  licit trade. 
Bilateral  agreements  on precursor control  with  third  countries  (Bolivia,  Colombia, 
Equator, Peru and Venezuela), Chile, Mexico and the United States have paid off as 
they  contribute  greatly  to  a widespread  information-sharing in the  combat  against 
precursor  diversion.  The  conclusion  of similar  bilateral  agreements  with  more 
countries and regions in the world should be pursued as  a good basis for enhancing 
and extending the precursor control system; they should be placed under a regional 
approach in order to avoid illicit traffic in precursors circumventing national controls 
via neighbouring countries. Hence, under the framework of the Europe Agreements, 
the Community should also  soon start negotiations on precursor control agreements 
with  the  associate  countries of Eastern  and  Central  Europe  which  are  particularly 
important for the manufacture of  the so-called new synthetic drugs (amphetamines ...  ). 
Fighting  precursor  diversion  at  international  level  may  imply  the  exchange  of 
sensitive information on individuals or companies. This information is protected by 
national  and  Community legislation.  Nevertheless,  the Community has  managed to 
facilitate  such  an  exchange  by  concluding  the  above-mentioned  precursor  control 
agreement,  which  provides  the  indispensable  legal  coverage  for  the  exchange  of 
sensitive information. The Community should pursue this effort and streamline it as 
worthwhile  and  representing  a  major  success  of the  Community  in  curbing  the 
availability of  precursors for the illicit manufacture of  drugs. 
Addressing  the  problem  of precursors  for  new  synthetic  drugs  should  take  into 
account  the  large  number of these  precursors  on  the  market  which  have  a highly 
changing and evolving nature.  The above makes it unrealistic to establish a control 
mechanism similar to that imposed on the 22 scheduled substances because additional 
constraints on more substances could only result in weakening the global efficiency of 
the  precursor  control  system  while  hampering  the  very  productive  co-operation 
between operators and the authorities. 
The 22  precursors identified in  the  UN  1988  Convention are not sufficient to  fully 
address the precursor diversion issue. Therefore, bearing in mind the new challenge 
posed by new synthetic drugs, as described above, it is sensible to establish "special 
surveillance  lists"  for  non-scheduled  precursors.  Such  lists  should  reflect  in  an 
evolving perspective the diversion patterns in the Community of the chemicals under 
such surveillance lists, and the principle of  co-operation with industry. 
The G 7 Chemical Action Task Force recommendations of 1991  enshrined a targeted 
approach gearing the international precursor control mechanisms towards a specific 
22 and limited number of  chemicals consistent with the nature and trade patterns of  each 
product.  This  is  more realistic  and cost-effective than extended control on a  wide 
range of  chemicals. 
3.1.2.  Money laundering 
The  Commission's  Second  Implementation  Report  adopted  on  I July 1998
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concerning the Directive on the prevention of the use of the financial system for the 
purpose of money laundering
16  has been forwarded to the Council and Parliament. It 
records that all the Member States have implemented the Directive. The one current 
infringement procedure concerns Austria's anonymous savings books. 
The report also makes  a  fairly  positive assessment of the impact of the Directive. 
However,  an  important  aim  of the  Directive  is  preventive  in  nature  and  it  is 
impossible to assess how much money laundering may have been prevented. On the 
other hand the data on suspicious transaction reports set out in Annex 8 shows that the 
financial sector has responded fairly well to its responsibilities under the Directive. In 
short,  all  the  Member  States  continue  to  take  an  active  stance  against  money 
laundering. 
A money laundering experts subgroup of the Multidisciplinary Group analysed the 
effectiveness of anti-money laundering systems in respect of  co-operation under Title 
VI  of the  TEU  as  the  results  of the  anti-money  laundering  effort  in  terms  of 
prosecutions, convictions and assets confiscation remain relatively modest so far.  In 
order to  enhance  effective  co-operation  between  Member  States  in  this  area,  the 
Council adopted on 3 December 1998, on the basis of  Article K.3 of  the TEU, a Joint 
Action  on  money  laundering,  the  identification,  tracing,  freezing,  seizing  and 
confiscation of  instrumentalities and the proceeds from crime.
17 
Moreover, the Commission announced in its Second Report and in the accompanying 
press release  that work has  started  on  a  proposal  for  a  second  money  laundering 
Directive to extend and update the 91  Directive. This proposal will seek to give effect 
to the recommendations related to Community fields of  competence of  the Organised 
Crime Action Plan and to some of  the wishes expressed by the European Parliament It 
intends  in particular to  extend  the  scope  of the  directive  to  certain  non  financial 
activities and professions. 
Money laundering is a global concern and efforts to combat it can be effective only if 
all countries and regions of  the world share the same objective. However sophisticated 
the EU's (or FATF members') anti-money laundering systems may be they will be 
rendered  ineffective  if other countries  or regions  have  inadequate  or non-existent 
systems. Hence the importance of the Financial Action Task Force (FATF) and UN 
global efforts and the EU's external work in this area. 
F  ATF remains the foremost international anti-money laundering body and it has been 
decided that its mandate should be extended for a further five years as from mid-1999. 
15 COM {1998) 401 fmal 
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23 The  F  ATF  is  now  beginning  work  on  taking  in  a  small  number of strategically 
important new members and on the creation of  a world-wide network of  regional anti-
money laundering bodies. Work has also begun on two complex and sensitive tasks 
passed to the FATF by the G7/8, namely on non-co-operative jurisdictions (in terms 
of excessive banking secrecy and opaque corporate structures) and  the use of anti-
money laundering defences to combat tax fraud. 
The Phare programme has been particularly active in anti-money laundering efforts, 
including its support for the Council of Europe mutual evaluation project.  Work is 
now being launched under TACIS (feasibility study in Russia, Ukraine and Moldova). 
A major project has been launched with the US in the Caribbean and another project is 
in  execution  for  the  five  countries  of the  Andean  Community.  The  SADC  drugs 
control programme also has a money laundering component. Work is continuing to 
ascertain whether it will be possible to  co-finance anti-money laundering measures 
under ASEM. 
These  external  efforts  are  important  and  also  give  the  Commission  and  the  EU 
enhanced  international  visibility.  They  should  be continued  and  developed  even 
further. 
3.1.3.  Prevention of  the use of  new communication systems (e.g. Internet) as means 
of  developing drug abuse, production and trafficking. 
New technology, in particular Internet, can have both positive and negative impacts 
on drug misuse. As an example of  positive impact, Internet can be used to raise public 
awareness on drugs misuse and to provide accurate information on harm caused by 
drugs, especially new synthetic drugs.  As negative impact, Internet can be used for 
drug-related illicit purposes with a view, in particular, (i) to provide information on 
the chemical precursors and essential substances, access to specialist literature and to 
the market of laboratory equipment needed for the illicit manufacture of  drugs, (ii) to 
provide training on illicit manufacturing and (iii) to incite drugs abuse. 
The  European  Parliament  and  the  Council  by  a  decision  dated  25  January  1999 
adopted a multiannual Community action plan on promoting safer use of the Internet 
by  combating  illegal  and  harmful  content on  global networks. 
18  The  action  plan 
covers a period of four years from  1 January 1999 to 31 December 2002. with a total 
appropriation of 25  million EURO.  The implementation of the Internet Action Plan 
will in particular aims at (i) the creation of  a safer environment by the setting up of  a 
European  network  of hot-lines  where  improvement  of the  co-operation  between 
industry  and  law  enforcement  authorities  will  be essential  for  developing  the  full 
potential  of  the  hot-lines  and  (ii)  the  encouragement  of  awareness  actions. 
Responsibility  for  prosecuting and  punishing  those  responsible  for  illegal  content 
remains  with  the  national  law  enforcement  authorities,  assisted  by  Europol  in 
particular. 
11 Decision D
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3.2.  Synthetic drugs 
The Dublin European Council in December 1996 highlighted the necessity to give 
priority attention to synthetic drugs  both within the  EU and  in other countries,  in 
particular in Central and Eastern Europe and to tackle the problem at three  levels: 
(a) legislation; (b) practical co-operation against production and trafficking, including 
improved of  co-operation between national authorities and the chemical industry and 
(c) international co-operation.
19 
The recently established early warning system for new synthetic drugs
20
,  co-ordinated 
by Europol and the EMCDDA, should help in meeting the new challenges presented 
by the consumption and production of  these new drugs. 
In  its  Communication  on  the  control  on new  synthetic  drugs
21
,  the  Commission 
indicated that a later stage additional instruments might enhance the effectiveness of 
the fight against the illicit trafficking in and use of  synthetic drugs, based perhaps on a 
discussion  of the  relative  merits  of the  "emergency  list"  approach,  the  "generic 
. approach" or the "analogue approach" mentioned in the Communication. 
3.3.  Implementation of  Title VI of  the Amsterdam Treaty 
The Treaty of  Amsterdam 
The new legal framework provided by the Treaty of Amsterdam is described under 
chapter III  section D.  In  its  communication of 14  July 1998  "Towards an  Area  of 
Freedom,  Security  and  Justice"
22
, ·  the  Commission  indicated  that  the  Treaty  of 
Amsterdam will further enhance the Commission's ability to make its contribution to 
the Union's fight against drugs, also in areas where it previously had no formal right 
or initiative. 
The Action Plan on an area of  freedom, security and  justice 
Our  approach  in  the  abovementioned  communication  has  been  taken  into 
consideration in the Action Plan of the Council and the Commission on how best to 
implement the provisions of  the Treaty of  Amsterdam establishing an area of  freedom, 
security and justice, which was endorsed by the European Council of  Vienna. 
Drugs  are  especially  mentioned  in  the  Action  Plan  when referring  to  the  area of 
security.  Concretely,  the  Action  Plan  mentions  that  drugs  constitute  a  threat  to 
collective and individual security in numerous ways, often but not always linked to 
organised  crime.  It indicates  that  it  is  an  area  to  which  Europe  has  brought  a 
distinctive and influential approach through its insistence on a comprehensive policy, 
19 The joint EC/EP Presidency conference on synthetic drugs  (Brussels, 27-28.11.97) issued a number 
of  recommendations on how to tackle the problem on all fronts (prevention, information, research, 
health promotion and treatment, supply reduction and law enforcement). LffiE 103 EN. PE 167.784 
20 Joint Action adopted by the Council on 16 June 1997 on the control of  new synthetic drugs 
(OJ N° L 167 of25.06.1997) 
21  COM(1997) 249 fmal of23.05.1997, p. 5 
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25 based on shared responsibility between consumer and producer countries. Within that 
comprehensive framework, it is clear that a major component will be the mobilisation 
of all  available judicial and  law  enforcement  resources  against  the  traffickers  and 
criminal organisations. 
Co-operation at EU level between police, customs and other law enforcement services 
of the Member States deserves special attention.  The Action Plan implementing an 
area of  freedom, security and justice supports and enhances the co-operation between 
all  these  law  enforcement  services  as  this  is  what precisely will  contribute to  the 
effectiveness of  the Union's efforts to counter the drug problem. 
In the aspects of law enforcement co-operation and judicial co-operation in criminal 
matters,  the  Action  Plan  implementing  an  area  of freedom,  security  and  justice 
contains a timing of  measures to be adopted in two and five years after the ratification 
of  the Treaty of Amsterdam. Those measures to be developed and implemented will 
have a real  impact  on  drug  trafficking  and  illegal  drug  related  activities,  such  as 
money laundering. 
In the  area of drugs,  all  the  measures  proposed in  the  Action  Plan  are  extremely 
important but perhaps most significant are those which are referred as needing to be 
taken within two years of the entry into  force of the Treaty.  These measures cover 
both police co-operation and judicial co-operation in criminal matters. 
Under police co-operation, the Action Plan focuses on Europol work on operational 
co-operation. 
23 Other police and customs co-operation measures comprise: 
- the  common  evaluation  of particular  investigative  teclmiques  in  relation  to  the 
detection of  serious forms of  organised crime (e.g. controlled deliveries, surveillance); 
- consideration of the arrangements under which a law enforcement service from one 
Member State could operate in the territory of another, taking into consideration the 
Schengen acquis. 
Equally significant, in the aspect of  co-operation within the framework of  Europol, are 
the following measures to be accomplished within the period of  five years: 
- to  promote  liaison  arrangements  between  prosecuting/investigating  officials 
specialising in the fight against organised crime; 
- to establish a research and documentation network on cross-border crime; 
- to improve statistics on cross-border crime; 
- to  set  up  a  system  for  the  exchange  of information  and  analysis  on  money 
laundering. 
23 One of  the priorities stated by the Treaty of  Amsterdam is to determine the nature and scope of  the 
operational powers of  Europol, which will have to be able to "ask the competent authorities of  the 
Member States to conduct and co-ordinate (their) investigations" and also to act within the framework 
of"operational actions of  joint teams". 
26 Under  judicial  co-operation  in  criminal  matters,  the  Action  Plan  refers  to  the 
establishment of minimum rules relating to the constituent elements of criminal acts 
and penalties in the field of  drug trafficking as a measure to be taken within two years 
of  the entry into force of  the Treaty of  Amsterdam. 
The  integration  of the  Schengen  Acquis  in  the  field  of drugs  will  constitute  an 
important  element  taking  into  account  the  operational  activities  and  measures 
undertaken in the framework of  Schengen which have led to an increase of  the general 
efforts to curb drugs trafficking. 
Finally, the Action Plan makes a reference to the enlargement process linking it with 
. the pre-accession strategy.  Justice and  Home Affairs  matters  are  a priority for  the 
European  Union.  The  measures  proposed  by  the  Action  Plan  will  contribute  to 
reinforcing the Justice and Home Affairs Acquis,  setting out for the benefit of the 
applicant countries a clear and comprehensive statement on the Union's priorities in 
this area. 
4.  Action at International/eve/ 
The  international dimension of the fight  against drugs requires more intensive co-
operation. This co-operation needs to be developed with target countries and regions 
in support of national and/or regional plans (master plans), where they exist, on the 
basis of guiding principles, using to  the full  all existing instruments (development, 
technical,  financial  and  trade,  political  dialogue,  co-operation in justice and  home 
affairs). Co-operation of the EU with industrialised countries and with UNDCP and 
other relevant international fora and groups will need to be continued and enhanced. 
•  Basic principles of  the international co-operation 
The seriousness and the common threat that drugs pose to  both the  developed and 
developing countries, requires a more intensive co-operation at country, regional and 
global level.  The 1998 United Nations General Assembly Special Session on Drugs 
(UNGASS) recognised that international drug control co-operation needs to be seen as 
part of  overall efforts to foster social and economic development in a broader sense. 
Through  the  adoption  of the  Political  Declaration  by UNGASS,  the  international 
Community, including the EU, has subscribed to some basic principles: 
Shared  responsibility:  action  against  drugs  is  a  common  and  shared 
responsibility requiring an integrated and balanced approach; 
Integrating  drugs  control  into  mainstream  development:  demand/supply 
reduction  efforts  must  be  integrated  and  supportive  of existing  socio-economic 
development policies, 
Balanced  approach  between  demand  and  supply  reduction:  demand 
reduction has for the first time been recognised as one of  the main pillars of a global 
drugs strategy; 
27 Respect for human rights, 
Support  for  multilateral  approaches:  drugs  control  problems  are  to  be 
addressed in a multilateral setting; the UN (UNDCP) is hereby reconfirmed as a centre 
of  excellence and valuable focal point for knowledge about drug related issues. Other 
specific international organisations can also provide valuable experiences. 
•  Implementation ofUNGASS 
At the meeting of  the UN Commission on Narcotic Drugs (CND) which took place in 
Vienna  on  March 1999  important  steps  have  been  taken  by  the  international 
community  including  the  European  Union  to  support  the  implementation  of the 
various Action Plans and other measures adopted in June 1998 by the Special Session 
on Drugs of the United Nations General Assembly (UNGASS).  The Action Plans 
concern (i) the International Co-operation on the Eradication of  Illicit Drug Crops and 
Alternative Development, (ii) the Guiding Principles of  Drug Demand Reduction and 
(iii) the Illicit Manufacture, Trafficking and Abuse of Amphetamine-type Stimulants 
and their Precursors. The other measures relate to the control of precursors, judicial 
co-operation and money laundering. 
•  Integration of EU international co-operation in the  fight  against  drugs  into  the 
broader objectives of  EU external relations 
The EU has recognised the important role of  drug concerns also in foreign policy by 
applying two  broad  categories  of action.  Firstly,  multilateral  action  is  undertaken 
through  (i)  active  support  for  global  policy-making,  (ii)  strengthening of strategy 
setting by UN institutions and (iii) effective functioning of  informal bodies. Secondly, 
bilateral action and regional actions are carried out through three types of  instruments 
for co-operation with third countries: political dialogue, trade policy and technical and 
financial  assistance.  The  EU  will  need  to  continue  to  integrate  international  co-
operation  in  the  fight  against  drugs  into  the  broader  objectives  of EU  external 
relations. 
•  Full use of  EC instruments for international co-operation (development, technical 
and financial assistance and trade instruments such as the Generalised System of 
Preferences) 
The EC will need to make full use of EC instruments for international co-operation 
(development, ·technical and  financial  assistance  and  trade  instruments  such as  the 
Generalised System of Preferences) in the context of third countries and/or regions 
strategies and development plan.s. This implies that drugs control needs to be seen as 
an integral part of EU development co-operation.  As far  as  GSP is  concerned, the 
Commission  deems  it  useful  to  continue  the  special  commercial  arrangements  in 
support of the efforts to address illicit crop production, provided that the countries 
concerned continue their efforts to combat drugs and that results are achieved. Based 
on an evaluation of the GSP impact on combating drugs,  the  agricultural EC  GSP 
scheme granted to the Andean and Central American countries was extended until 
31  December 2001  and the industrial scheme was also granted to Central America for 
the first time. 
28 •  Full use of CFSP instruments in bilateral co-operation and within the multilateral 
framework including political dialogue, common positions and joint actions 
The Treaty offers scope for stronger overall external action against drugs, through the 
common  foreign  and  security  policy  (CFSP),  which  provides  for  the  use  of joint 
action  in  particular  areas  in  which  Member  States  have ·important  interests  in 
common, and for the establishment of systematic co-operation in the European Union 
in areas of general interest. So far, EU actions have mainly taken the form of  political 
dialogue  with  third  countries.  The  dialogue  has  been  further  advanced  by  the 
systematic  inclusion of drugs clauses  in  co-operation agreements.  Furthermore, the 
EU has regularly co-ordinated its activities in international fora. 
These activities must be continued and  enhanced as  an  integral part of the EU  co-
operation with third countries both in multilateral and bilateral fora. As far as bilateral 
relations are concerned,  further emphasis should also be given to  the link between 
development co-operation and third countries' political commitment to promote good 
governance, the rule of  law and respect ofhuman rights. 
•  Development of  international co-operation in JHA matters 
There is an increasing need to  develop a coherent approach concerning the issue of 
how the EU should co-operate with third countries and regions in combating illicit 
drug trafficking.  This aspect is  already an  important component of the major drugs 
initiatives carried out by the EU in Latin America, the Caribbean and Central Asia. 
Provisions also exist for co-operation in this field in a large number of co-operation 
(and partnership) agreements with third countries and regions. Combined efforts of  all 
competent authorities in the EU will be needed, with a particular role for Europol in 
the areas of intelligence gathering and analysis and in helping to co-ordinate national 
investigations.  The  Commission  will  contribute  to  these  common  efforts  mainly 
through  effective  co-ordination  with  first  pillars  instruments  (money  laundering, 
precursors) and through availability of  existing funds, whenever possible. 
•  Operational  co-ordination  between  the  Commission  and  the  Member States  in 
identified  third  countries/regions  for  the  purpose  of joint  assessment  and 
implementation of  programmes 
The effective implementation of  a comprehensive and integrated response to the drugs 
phenomenon at the level of  the Union will call for action at different levels. Equally it 
involves  a  wide  range  of players  both  governmental  and  non-governmental.  The 
implementation of this  Action Plan will  require  an  ongoing co-ordination effort to 
assess jointly and to implement the programmes. 
•  Main target countries and regions 
Main  target  regions  are  the  candidate  countries
24
;  Latin  America/  Caribbean  and 
Central Asia extended to Transcaucasia. 
24 See description of  the Phare Drugs Programme on pages 8-9 
29 As  far  as  Latin  American  countries  are  concerned,  the  EU  expects  to  further 
strengthen the dialogue on this matter with the different sub-regional groups, as well 
as the specialised dialogue on drugs with the Andean countries. Furthermore, the EU 
expects that Latin American countries will play a keY' role in the new mechanism on 
drug  co-operation/co-ordination  between  Europe  and  Latin  American/Caribbean 
countries, whose first meeting took place in April 1999. In the field of  co-operation, a 
comprehensive Action Plan for  Latin America has been adopted. This Plan stresses 
the -importance  for  both  sides  to  maintain  a  balanced  approach  to  the  problem, 
reaffirms the importance of the principle of shared responsibility and defines a list of 
topics on which the  Commission and the  Members States' aid should focus  in  the 
future with a view, in particular, to reinforce the inter-regional co-operation between 
Latin America and the Caribbean as well as between the various Latin American sub-
regional groups. 
The EU Caribbean drugs initiative has significantly improved co-operation and co-
ordination of drugs control actions both among the Caribbean countries, as  well as 
among  donor  countries,  to  the  benefit  of the  region.  The  establishment  of a 
Commission Drugs Control Office in Barbados has ensured a high visibility of  the EU 
in the area of drugs control and has improved the monitoring of Community funded 
drugs control  activities, amounting to  approx.  20 million EURO,  in support of the 
Barbados Plan of Action.  In  this  context,  the  setting  up  of the  EU/Caribbean/US 
maritime co-operation office (PMO) has facilitated a closer dialogue and enhanced co-
operation in  the  field  of maritime co-operation to  address the problems relating to 
drugs trafficking. 
There is  a high  level  of movement of drugs  from  Afghanistan and  its  neighbours 
through the NIS, mainly directed at the EU. Co-operation in the framework of Tacis, 
related to drugs issues, is covered by three programmes:  (i) Customs Co-operation, 
(ii) Border Crossing Programme, and (iii) Justice and Home Affairs, a programme that 
is now under development. The Customs programme in Central Asia, particularly but 
not  exclusively,  assists  in  establishing  effective  border  controls,  and  the  use  of 
investigative  methods,  including  profiling  and  risk  analysis  in  identifying  the 
movement  of  drugs.  The  Border  Crossing  Programme  provides  support  and 
infrastructure for all agencies working at specified crossings between the West of the 
NIS and Central Europe and the EU. It  provides assistance to all enforcement agencies 
at  the  crossings  and  is  expected  to  have  an  impact  on  trade  facilitation,  while 
increasing detection rates in the movement of  illicit substances. The JHA programme 
targets in addition other agencies, such as Ministries of  the Interior and police forces, 
particularly  in  Central  Asia  and  the  Caucasus,  with  support  to  institutional 
strengthening, with activities foreseen at the operational level, at airports and border 
crossings in particular. Emphasis is also being given to money laundering in Russia, 
Ukraine and Moldova. Moreover programme activities are currently being developed 
in close co-ordination with, inter alia, UNDCP and UNDP. 
Another  main  objective  is  to  further  progress  the  dialogue  with  North  African 
countries (especially Morocco) and Middle Eastern countries under Euro-Med, as well 
as to promote co-operation with countries of the SADC region (Southern Africa) and 
the West African region. Southern Africa is a new target region for EU co-operation 
in the field of  drugs. The start was launched in Mmabatho/South Africa in November 
1995 and the political commitment was reconfirmed at the EU/SADC Drugs Control 
30 Conference of Gaborone in February 1998. At the EU-SADC Ministerial meeting in 
Vienna in November 1998, the EU committed itself to support the implementation of 
the SADC Regional Drugs Control  Action Plan.  Regional programmes have  been 
launched  in  16  West  African  countries,  aimed  at supporting  the  development  of 
national  masterplans,  adequate  institutional  structures,  as  well  as  appropriate 
legislation to counter the drugs threat in the region. 
Another region where co-operation should be developed and enhanced in the coming 
years, is Asia, in particular with China and with the Asian ASEM partners. As regards 
China, the Commission's Communication, "Building a Comprehensive Dialogue with 
China", of  March 1998, underlines the necessity to promote a substantial dialogue and 
encourage  co-operation  with  this  country  on various  issues,  including  combating 
illegal drug trafficking. This commitment should be developed and China should be 
involved in the international activities for combating drugs trafficking. The first step 
in developing a constructive dialogue with China is the identification of  the nature and 
magnitude of  the problems related to illegal drugs trafficking in the country. The issue 
should then be discussed with China in the framework of the EU -China Political 
Dialogue. 
Co-operation  with  the  Asian  countries  in  the  framework  of ASEM  should  be 
enhanced. Initiatives such as the exchange of  senior customs officials and seminars for 
customs officials should be continued and similar actions should be developed on a 
wider basis. 
•  Continuation of bilateral  co-operation  with  the  industrialised  countries  (USA, 
Canada,  Japan)  and  strengthening  of  multilateral  co-operation  in  relevant 
international fora, such as the G8 and the Dublin Group 
Co-operation with our industrialised partners should be strengthened both bilaterally 
and  within  multilateral  fora.  Our  first  objective  should  be  the  support  of 
implementation  of integrated  and/or  regional  policies  and  programmes,  with  the 
overall aim of  promoting dialogue and ownership on the part of  the recipient country.· 
At  the  same  time,  we  should  aim  at  enhancing  complementarity  of our actions. 
Complementary is best ensured  when co-operation  is  based on commonly agreed 
needs-assessment at country and sectoral level. Assistance may then be allocated on 
the  basis  of the  comparative  advantages  of individual  donors  and  in  respect  of 
potential political concerns and interests 
At the bilateral level we should establish strong channels of  communication to ensure 
the exchange of  information on illegal drug trafficking and related organised crime. 
The best example of successful  co-operation with an industrialised partner,  is  the 
comprehensive EU -US co-operation under the New Transatlantic Agenda (NT  A). 
This relationship should be continued and strengthened. In the coming years the two 
partners will continue working on joint projects, such as the Caribbean Initiative, and 
will  look  for  other constructive  actions  in other regions of the world,  notably  in 
Southern  Africa,  Nigeria,  Eastern  Europe,  Central  Asia,  Latin  America/  Andean 
region. 
31 The EU -US will also continue co-operation between American and European law 
enforcement agencies and will continue to work together on the implementation of 
international Conventions. 
Our co-operation with Canada and Japan should also be enhanced. Co-operation with 
Canada will take on new dimensions in the next few years since Canada has recently 
finalised  its  internal  drugs  policy  and  is  now  working  on  the  definition  of an 
international policy on drugs. In this framework, co-operation with the EU on drug 
related issues will be broadened. 
Japan has expressed its intention at the EU-Japan Summits, to set up a dialogue in the 
field of  combating drug trafficking, which could develop into a regular exchange of 
information  within  an  expert  group.  The  possibility  of concluding  a  precursors 
agreement with Japan should also be noted. 
Discussions within the GS  framework should be continued and enhanced.  GS  have 
recognised the link between drugs and wider international and domestic crime and 
have  committed  to  partnership  and  shared  responsibility  in  the  international 
community to combat illicit drugs.  This  should include reinforced co-operation to 
curb illicit trafficking in drugs and chemical precursors,  action to reduce demand, 
including  through  policies  to  reduce  drug  dependency,  and  support  for  a  global 
approach to eradicating illicit crops. 
Another important forum where the industrialised countries can discuss drug related 
issues, is the Dublin Group. It is an informal consultation mechanism of  major world 
players,  which  regroups  the  EU  Member  States  and  the  Commission,  Australia, 
NOIWay,  Canada, Japan and the US. The United Nations Drugs Control Programme 
(UNDCP) also participates in the meetings. The main global meetings are held twice a 
year. Their discussions are based on regional reports collated from reports prepared at 
national (local) level by the so-called ''mini-Dublin" groups. 
•  Co-operation with international organisations 
Co-operation with international organisations competent in the field of  drugs should 
be continued and enhanced. The European Community sees in particular UNDCP as a 
centre of excellence and a valuable focal  point for  knowledge about drugs related 
issues. UNDCP is an important partner that can offer comparative advantages iiJ  its 
services,  while  representing  the  main  co-ordinating  tool  for  co-ordination  of 
international drugs control activities.  Other specific international organisations can 
also provide valuable experience and partnership, such as for example CICAD. 
5.  Co-ordination, illlegration and simplification 
Co-ordination is essential due to the multi-facets of the drugs phenomenon and  the 
"inter-pillar'' aspects of  action taken by the EU. Co-ordination should be enhanced at 
all levels and involve all EU institutions and entities. 
32 5  .1.  Co-ordination at Council level 
Co-ordination of drugs activities of the  EU  is carried out by the Horizontal Drugs 
Group (HDG), set up by COREPER in February 1997. Its mandate is to monitor and 
co-ordinate  all  cross-pillar  activities  in  the  field  of drugs  and  to  report  back  to 
COREPER. The remit of its activities includes international cross-pillar drug control 
initiatives carried out by the EU in specific geographic areas which have been targeted 
by successive European Councils (i.e. Caribbean, Latin America, Central Asia). Given 
the variety of interest of Member States towards the different regions where drugs 
initiatives are  taken,  it  can  be appropriate,  in  some cases,  to  follow  a flexible  and 
pragmatic approach in terms of  co-ordination.  The setting up of  specific informal co-
ordination groups between concerned Member States, in the framework of the HDG, 
has  significantly improved co-ordination between Community funded  and  Member 
States bilateral drugs control activities. Informal co-ordination groups have been set 
up for the Caribbean,  Latin America and Central Asia. 
The  HDG can draw on the experience of specific Working Groups of the Council 
which look at particular aspects of  the drugs phenomenon such as: 
-the Common Foreign and Security Policy (CFSP) Council Working Group on 
Drugs  (CODRO)  which  is  engaged  in  co-ordinating  and  taking  forward  foreign-
policy  initiatives  related  to  drug  control  co-operation  with  third  countries.  In  this 
context, the EU has  in  particular urged  those countries that have not yet signed or 
ratified the three UN Conventions, to do so. 
- the  Health  Group that  examines  issues  linked  in  particular  to  the  Community 
Action Programme on the Prevention of  Drug Dependence. 
- the  Economic  Question  Group that  examines  issues  linked  to  the  control  of 
chemical precursors. 
- the  General  System  of  Preferences  Group  responsible  for  following  the 
implementation of  the GSP system. 
- various working groups set up under Title VI of the TEU such as the customs co-
operation group and the police co-operation group. 
5.2.  Co-operation between the institutions and other entities of  the EU 
In general, co-ordination between the EU institutions and other entities of the EU on 
drugs  issues  should  be  encouraged  in  order  to  ensure  a  coherent  and  consistent 
approach at EU level to drugs policies and strategies. 
The  informal  co-ordination  on  drugs  issues  initiated  in  1995  by  the  European 
Commission  with  the  European  Parliament,  the  Presidency  of the  Council,  the 
Economic and Social Committee and the Committee of the Regions made a valuable 
contribution  to  the  mutual  understanding of drugs  policies  undertaken  in  the  EU 
Member States and to the identification of common trends on how drugs issues are 
dealt with in practice in the EU. 
33 IV.  CONCLUSIONS 
The ambition of this Action Plan is to provide the EU with appropriate means and 
tools to  combat drugs.  Taking into  account the need for  co-ordinated action at all 
levels,  it  should contribute to  ensure a truly comprehensive and balanced approach 
towards the  drugs phenomenon and to  concentrate on high priority targets.  It will 
benefit  from  its  strengthened  collection  of information  tools  and  co-ordination 
structures. 
The systematisation of  evaluation and the improvement of  the monitoring of  the drugs 
problems will contribute to ensure cost efficiency and facilitate rapid decision making 
at appropriate levels. 
In the area of demand reduction, the Action Plan stresses that the EU should put the 
highest  priority on prevention,  relating  to  health,  education,  research  and  training 
activities and on instruments to combat social exclusion. It encourages the exchange 
of experience and best practices and the support to networks at  city levels  and to 
networks  of professionals.  It emphasises  that  adequate  resources  should be made 
available for these activities. 
The next  few  years  will be crucial  in the development of a  coherent approach to 
combating drugs in sport. The Member States and the Commission have announced 
their  willingness  to  help  in  setting  up  an  international  agency  to  deal  with  this 
problem in co-operation with sports organisations. 
In  the  field  of supply reduction  and  action  against the illicit trafficking of drugs, 
priority should be given by the EU to enhancing measures and instruments relat~ to 
the control of chemical precursors diversion within the EU and in third countries, to 
the prevention and the fight against money laundering, to the effective co-operation 
between police, customs and judicial authorities, to the integration of Schengen drug 
related activities, to the implementation of the EU Action Plan on Organised Crime 
and to co-operation with third countries and regions in the fight against illicit drugs 
trafficking. 
In the field of international co-operation, the EU will systematically integrate drugs 
control  components  into  its  development  co-operation  policies.  Always  under the 
principle of shared responsibility,  the EU intends to place a  high priority to drugs 
control in the context of its development co-operation with national governments and 
regional organisations, which take appropriate measures to set up national plans for 
drugs control and which show a strong political commitment to the fight against illicit 
drugs.  Control  and  monitoring of all  drugs  control  activities,  including alternative 
development, is important. 
In parallel with relevant development co-operation activities, drugs issues should be 
regularly addressed  in the context of the political dialogue with the countries and 
regions  concerned.  Furthermore  the  EU  will  continue  to  actively  participate  in 
international fora in order to enhance the effectiveness and efficiency of global and 
regional  drugs control efforts.  Co-ordination of international  donors drugs control 
efforts  is  essentiaL  In this  context  our established  relationship  with  industrialised 
partners should be enhanced. We should work together in the identification, financing 
and implementation of  projects in regions of the world most affected by drug-related 
problems, ensuring thereby complementarity of  our actions. 
34 Annex I 
TOWARDS AN EVALUATION OF EXISTING EC AND EU 
INSTRUMENTS AND PROGRAMMES 
The  Commission  took  itself  the  commitment  to  present  a  report  on  the 
implementation  of the  1995-1999  Action  Plan  and  to  come  up  with  appr<Jpriate 
proposals for the  five-year period 2000-2004.
25  Evaluating the various Community 
and European Union instruments and programmes related to the drugs phenomenon 
and covered by  the Action Plan has  only been achieved partially as  demonstrated 
below. 
I  INFORMATION 
Since 1995, the EMCDDA in close collaboration with the "REITOX" National Focal 
Points in each Member State produced three reports on the drug situation in Europe, 
developed five common key indicators for data collection. It also published research 
reports on specific topics, such as Epidemiological Trends and responses to the use of 
new synthetic drugs, Efforts were concentrated on four main principles with respect to 
demand reduction (prevention, harm reduction, care and rehabilitation): 
•  the definition of  a suitable terminology, methodology and technology for the 
effective exchange of  information on the scale of  the Union, 
•  the promotion of systematic and  scientific evaluation and the provision of 
tools and guidelines to be used by researchers and professionals; 
The  EMCDDA jointly with  the REITOX  Focal  Points has  developed other tools, 
including  the  EDDRA  database,  an  information  system  on  demand  reduction 
activities, which not only has great potential as an instrument for policy-making, but 
also  as  a  resource  for  experts  interested  in  comparing  methodologies  and  good 
practice or to initiate partnerships with initiatives in other Member States. Currently, 
EDDRA carries information on more than 100 projects operating in Member States. 
All  of  the  projects  registered  have  to  fulfil  quality  standards  established  in 
collaboration with Member States. 
Another initiative il!lplemented by the EMCDDA has been the Early Warning System 
on new synthetic drugs, constituting a relevant and timely tool for the rapid adoption 
of  prevention strategies and activities particularly directed at young people. 
An independent external evaluation study of  the EMCDDA will be launched in 1999 
and results are expected before the end of  the year. 
25 Communication from the Commission to the Council and the European Parliament on a European 
Union Action Plan to combat Drugs (Com(94) 234 final of23.06.94; page 33. 
35 II.  ACTION ON DEMAND REDUCTION 
2.1  The first five-year programme of  Community action on the prevention of  drug 
dependence(1996-2000Y: 
The  Treaty  on  European  Union  identified  drug  dependence  as  a  pnonty  for 
Community action in the field of public health. The Commission considered that the 
best way to consolidate and develop existing achievements was to launch a specific 
drug prevention programme. The five-year Community programme for the prevention 
of drug dependence (1996-2000)  was  adopted  in  December  1996  by the  European 
Parliament  and  the  Council,  after  consultation  with  the  Economic  and  Social 
Committee and the Committee of  the Regions. It was launched in January 1997, for a 
period  extending  to  the  end  of the  year  2000  and  with  an  overall  budget  of 
27 million ECU. 
The Programme  fits  within a dual  context,  namely the  framework  for  Community 
action in the field of public health
27  and the European Union Action Plan to  combat 
drugs  (1995-1999)  to  which  it  contributes  to  the  section  on  "Action  on  demand 
reduction". 
The aims of  the programme are to encourage co-operation between Member States, to 
provide support for  their actions and to  promote co-ordination of their policies and 
programmes with a view to preventing drug dependence. The programme also strives 
to enhance co-operation with third countries and international organisations active in 
the field of drug prevention. The actions are implemented in close co-operation with 
Member States,  and  the  Commission is  assisted  by a committee of officials  from 
Member States and the EEA countries. 
16 priority actions are to be implemented by the year 2000, grouped under two main 
headings: (a) Data, research and evaluation and (b) Information, health education and 
training. 
On the basis of annual programmes of activities which identify priorities, the main 
characteristics of the  projects  funded  involve exchanges between professionals and 
encouragement of interaction between researchers and practitioners; improvement of 
methods for identifying needs (prevention/treatment) and factors favouring prevention 
and treatment;  and the common testing and  assessment of prevention tools.  In this 
context, a number of transnational networks have been set up, such as the European 
Addiction Training Institute (EATI) with Focal Training Points in Athens, Amsterdam 
and  Helsinki,  the  European  Network  of Drug  and  HIV/AIDS  services  in  Prisons 
(ENDHASP),  the  European  Peer Support Project (EPSP),  Drug  Addiction-Europe-
Exchange-Training (T3E), the Federation of European Professionals working in the 
field of drug abuse (ERIT), the European Foundation of Drug Help lines (FESAT), 
EURO-METHWORK,  forum  for  exchange  of  expertise  between  providers  of 
methadone in European countries, IREFREA, network for research and evaluation on 
prevention. 
26 OJ N° 19 of22.01.97 
27 Art 129 and Commission Communication of24.11.1993, COM (93) 559 fmal. 
36 All this is with a view to  defining, improving and implementing prevention models 
for particular target groups or particular environments. Many projects have a strong 
focus  on multidisciplinary  co-operation  and  co-ordination  between  the  public  and 
private sectors. 
Of  particular interest are the following projects: 
•  Development of co-operation between cities:  exchanges of experiences on 
local prevention and risk reduction strategies; encouragement of  and support for 
multidisciplinary  co-operation;  setting  up  of a  pool  of European  experts  on 
specific ·themes  and  promotion  of innovative  projects;  diagnoses  and  pilot 
projects concerning the social and health aspects of  drug tourism between cities 
particularly affected by the phenomenon; 
•  Improvement of  strategies and practices aimed at specific and/or particularly 
vulnerable groups: 
(a) promotion and evaluation of  programmes for the treatment of  drug addicts 
in prison; pilot projects in this domain; drafting of guidelines on preventive 
measures and risk reduction measures in prisons; training prison and extra-
prison  personnel  in  managing  drug  dependence  problems  in  the  prison 
environment and in improving practices; 
(b) promotion of research and of the use of research results relating to  the 
treatment of  drug-dependent parents and patents-to-be and their children; 
(c)  diagnosis,  promotion  and  evaluation  of strategies  for  reaching  groups 
identified  as  particularly  vulnerable,  such  as  ethnic  minorities,  migrant 
populations, certain groups of  addicts; 
(d) development of  expertise on drug substitution programmes (methadone in 
particular),  and  creation  of a  reference  network  for  persons  travelling  in 
Europe  while  in  the  process of treatment  for  addiction;  evaluation  of the 
impact of  syringe distribution programmes in the Mediterranean basin. 
•  Adaptation and improvement of practices targeting young persons and new 
forms  of drug  use:  comparison,  evaluation,  testing  and  dissemination  of new 
approaches  for  preventing ecstasy use;  use of new  technologies  for  preventive 
ends,  including  in  the  world  of  education;  promotion,  improvement  and 
adaptation of  services, including drug help lines services; 
•  Identification  and  exploitation  of promising  approaches  in  the  field  of 
primary  prevention,  with  the  development  of exchanges  and  co-operation 
between responsible local bodies, education professionals, social workers, etc ...  , 
testing  and  promotion of prevention  tools  of approaches  based on  involving 
citizens, including young persons, in local prevention strategies; 
•  Training: On the basis of the result of a seminar organised by the European 
Commission  in  November  1997,  it  is  envisaged  to  promote  initiatives  to 
improve  the  drug  prevention  aspect  of vocational  training  programmes  for 
37 teachers and those responsible for young people and to encourage exchanges of 
students.  Priority will  also be given to support to  the development of further 
training programmes, teaching materials and modules for those likely to come 
into contact with drug users and .groups at risk. 
The third  European Drug Prevention Week was held in  November 1998,  under the 
motto: "Talking is the first step". In the field of awareness raising in the society and 
partnerships  a  wide  range  of  activities  was  implemented  in  the  16 countries 
participating, as well as on a transnational level. Several of  the national projects were 
implemented on a long-term basis and will consequently have impact in the future. 
After a call for tender was published, an extensive communication campaign was set 
up by Publicis Etoile, Paris, in close co-operation with the national coordinators and 
the Commission. The campaign included a 30-second TV spot, a radio commercial, a 
press advertisement, a booklet in 16 languages and a poster. The week was launched 
by a two-day international conference on drug prevention and policy, organised by the 
city  of Vienna  in  co-operation  with  UNDCP  and  with  the  support  from  the 
Commission. 
External evaluation of the Community Action Programme on the Prevention of Drug 
Dependence is ongoing. A mid-term report will be transmitted to the Parliament and 
the Council during the first half of 1999. 
Some main results from the mid-term  evaluation are: 
Implementation of  most of  the actions of the Programme commenced during the first 
two years of  the 5-year programme. However, much remains to be achieved in areas 
such  as:  relapse  prevention  and  rehabilitation;  evaluating  the  effectiveness  of 
information and health education campaigns;  tools with polysubstance dependence; 
the  extension  of European  network  of 'test  towns'  and  promoting  initiatives  to 
improve the drug prevention aspect of  vocational training of  teachers; and, health and 
social care professions and other professionals responsible for young people. 
Much  also  depends  on  follow  up  of the  projects  and  on  opportunities  for  the 
EMCDDA  and  other  European  institutions  to  disseminate  results,  because 
dissemination by the project contractors often remains quite restricted.  In the same 
vein, funding of  European networks in the field of  public health action related to drug 
dependence should be a priority, with the aim to disseminate project results. 
There  are  quite  impressive  results  from  a  number  of projects.  Many  of the 
multinational networks and  teams  supported by the programme seem to  be a quite 
cost-effective way of  creating Community Added Value. However, the project reports 
of  the networks quite often fail in giving a convincing picture of  their actual capacity 
to  gather  expertise  and  experience  from  all  the  Member  States  and  from  all  the 
relevant agencies in the Member States, as well as to disseminate information when 
provided through these networks. A positiv~ development is the number of  networks 
that have proceeded in providing electronic information channels such as  websites, 
electronic databases and other uses of  the Internet. 
38 The projects funded  seem to  emphasise approaches targeted directly to  individuals, 
contrasted  with  a  lack of projects  with  a broader public  policy  approach  towards 
public health problems related to  drugs.  Such projects would be needed to  increase 
knowledge  about  the  impact  of the  larger  public  policy  context  on  the  drug 
phenomenon and on the feasibility of specific intervention models in different public 
policy contexts. 
As there are large political debates, both at the international and EU levels and at the 
national and municipal levels, on future public policy strategies with regard to drug 
problems, there is a great need for research-based evidence to help policy makers to 
choose between different strategic alternatives. 
2.2  Employment initiatives (Employment-Integra and Youthstart) 
Employment is one of  the initiatives adopted by the European Commission and led by 
the Social Fund for the period 1995- 1999.  The total budget for the five years of the 
Employment  Community  Initiative,  including  both  EU  and  Member  State 
contributions is almost 3500 million ECU. The Employment Initiative aims at helping 
people  with  special  difficulties  in  finding  or  keeping  a  suitable  job  or  career. 
Employment has four different strands: 
YOUTHSTART (for disaffected young people) 
INTEGRA (for people excluded from the labor market) 
NOW (for women) 
HORIZON (for people with disabilities) 
Of these, the first two are of particular interest here.  Like all the four Employment 
Initiatives, INTEGRA and YOUTHSTART fund projects that are innovative and have 
a high degree of  local involvement. All the projects work in transnational partnerships 
with  projects  from  other  Member  States  and  a  number of good  practice  projects 
participate in group work led by the Member States at national and European level 
that aims at further developing the project products. The ultimate aim of the projects 
is to bring about positive changes in training and employment policies and practices 
and to share the information and experiences with all interested.  Projects encourage 
the people concerned to take more active control of their lives and to play a full  and 
recognized part in their local communities. 
EMPLOYMENT-YOUTHSTART aims to  bring about positive changes in training 
and employment policies and practices for young people, and to share the information 
and  experiences with all  interested.  In overall there are  not many YOUTHSTART 
projects that deal directly with drug addiction but many are developing strategies and 
approaches, which are relevant in relation to prevention of  drug abuse. These include, 
in  particular,  individualized  approaches,  which  require  the  active  involvement  of 
young people themselves in finding the most appropriate solution to their problems. 
The experience of the projects shows that the active involvement of young people is 
essential to their success and that the problems of  the young need to be approached on 
an individualistic basis. This approach has been the core activity of the majority of 
YOUTHST  ART  projects  and  they  can  therefore  offer  many  new  insights  and 
39 examples of good practices.  The idea of empowerment is closely related to that of 
active involvement. 
A good example Y  outhstart's preventive action is a project called the Phoenix Centre 
in Dublin that is primarily targeting adolescents living in the South Dublin Inner City, 
who, through a combination of  drug misuse, juvenile crime, and truancy, have become 
severely  marginalised  in  their  community.  The  project  aims  to  provide  a 
comprehensive retraining programme suitable to the needs of the target group, which 
will  ensure  their  development  as  peer  educators  (locum  workers)  in  their  own 
communities.  The  target  group  will  develop,  through  the  use  of  information 
technology, a preventive programme of educational inputs for  schools in their own 
communities. The second objective is to promote drugs awareness among the wider 
youth population and to address the role which drug misuse plays in rendering young 
people vulnerable within the educational system. 
EMPLOYMENT  -INTEGRA  is  the  biggest  single  initiat~ve  in  terms  of financial 
means  addressing  the  drug  problem  and  it  has  launched  projects  focusing  on  the 
integration into employment of the groups that are excluded or at risk of exclusion 
from the labor market. As a result of  two calls for projects ( 1995 and 1997), a total of 
1559 projects have been chosen to be financed by the European Social Fund with co-
financing by public or private sources in the Member States. 
INTEGRA puts special emphasis on migrants and refugees possibly discriminated in 
labor market as  a consequence of e.g.  racism or xenophobia.  More than half of the 
projects  concern  mainly  the  integration  of migrants  or the  reduction  of racial  or 
xenophobic discrimination. INTEGRA also works to support people in disadvantaged 
urban areas. Substance abusers form a significant proportion of  the people who benefit 
from INTEGRA (more than 20% of the projects). Other big target groups are groups 
like (Ex)-offenders, long-term unemployed and the homeless people. Many projects 
involve several target groups and develop transversal approaches. 
Within INTEGRA, priority is given to pilot projects which, among other things: 
ensure that people know about and can use the local services available 
help people to have better control of their own lives and to have an active role in 
making decisions affecting themselves 
encourage  self-employment  and  public-private  partnership,  hence  creating  new 
jobs. 
A good illustration of  this approach is an INTEGRA project in Athens called "Action 
for  the  socio-economic  integration  of drug  addicts".  It  is  led  by  an  NGO  in 
collaboration with a number of other local  and  national organizations.  A particular 
preventive objective of  the project is to help, through local intermediary actors, former 
drug dependent persons in helping them not to fall back to drug dependency. Overall, 
the project aims to integrate substance abusers into employment developing a range of 
integrated provisions: 
development of  self-help groups at neighborhood level, which deliver information 
counseling 
40 social skills training and training both to the needs of  the substance abusers and to 
thos~ of  local labor market 
collaboration  with  local  authorities  in  a  number  of preventive  activities  and 
awareness-raising actions. 
The. project is part of a transnational  partnership with other INTEGRA projects in 
Spain,  Belgium and Ireland.  This transnational  partnership has produced a manual 
covering  methodological  issues  for  socially  excluded  groups.  The  very  fact  that 
several Member States have been involved in developing the manual has ensured that 
it is applicable throughout the Union. 
2.3  The  educational  and  vocational  training  programmes  (Youth  for  Europe, 
Leonardo da Vinci and Socrates) 
Youth for Europe 
Youth for Europe is a Community action programme adopted in  1995. It covers the 
years 1995- 1999 and has a budget of 126 million ECU. The objective of  the Youth 
for Europe Programme is to contribute to  the educational process of young people. 
This is done by e.g.  facilitating  youth exchanges (within the  Community and  with 
third  countries),  encouraging  local  youth  actions  and  in  particular  the  access  of 
disadvantaged young people to the Programme's activities. 
The projects funded by the programme share aims such as: 
- promoting  the  awareness  of the  dangers  relating  to  exclusion,  including 
racism and xenophobia, through socio-educational measures for and by young 
people, 
- encouraging young people to  take  an  active part in society via non profit 
making associations and organisations, 
- encouraging independence,  creativity  ~d  entrepreneurial spirit among the 
young people, 
- allowing young to express their opinion and encouraging authorities involved 
to take heed thereof, 
The  Prognimme  activities  are  both  complementary  to  those  implemented  by  the 
Member States and to those envisaged by Community programmes on Education and 
Training  (Socrates  and  Leonardo  da  Vinci).  The  implementation  is  partially 
decentralised in order to take action as close as possible to the beneficiaries and to 
adapt to the diversity of  national systems and situations. 
Combating drugs is not one of  the major focus points of  this programme but is eligible 
within the activities:  facilitating youth exchanges, encouraging local actions and in 
particular the access of  disadvantaged young people.  Youth for Europe has financed 
several small projects related to the drugs problem. 
Leonardo da  Vinci 
The Leonardo da Vinci programme, adopted for a period of 5 years (1995-1999) has a 
key objective of supporting the development of policies and innovative action in the 
41 Member States, by promoting transnational projects which involve organisations with 
an interest in training. The programme is open to the 15 Member States and to most of 
the Central and Eastern European pre-accession countries. 
It is concerned with enabling vocational training to  prepare for  the professions of 
tomorrow, to  anticipate change, to prepare and experiment with new ways and new 
methods. Vocational training finds itself at the heart of Member States' strategies to 
respond to the economic and social challenges of  tomorrow. 
Combating drugs is not one of the major focus points of the programme but it could 
be  included  in  the  measures  concerning  action  against  social  exclusion.  The 
programme would enable preparation of,  for  example,  pedagogic material  to  raise 
awareness of  students and trainers. Within this context, Leonardo da Vinci has already 
financed projects related to the drugs problem: 
(i)  the  development  of flexible  educational  tools  and  methodologies  targeted  at 
assisting the re-integration of  young offenders through the training process, 
(ii)  the  design,  experimentation  and  implementation  of an  interactive  continuous 
training programme on drug addiction related information aimed at communication 
professionals, 
(iii) vocational training for young people leaving the penal system, 
(iv) the improvement of  the quality of  health and social vocational training. 
Socrates· 
The SOCRATES programme, adopted for a period of 5 years (1995-1999) aims to 
improve the quality and relevance of  education for children, young people and adults, 
by enhancing European co-operation and increasing access to the range of learning 
opportunities available across the Union. It is applicable to the 15 Member States of 
the EU and to the candidate countries as well as to Iceland, Liechtenstein and Norway. 
Combating drugs is not one of  the major focus points of  the programme and there is 
no specific action with this aim but it can be eligible as an educational theme at most 
levels of  education and actions within Socrates. 
Under the higher education,  ERASMUS  can contribute to prevention and research 
through Thematic Network projects. 
In the field of school education, COMENIUS may contribute to make teachers and 
educational staff aware of  the problem of  drug abuse, to promote school partnerships, 
training activities for teachers and intercultural educational projects: 
2.4  The Framework Programmes on Research,  Technological Development and 
Demonstration 
In  the  context of the  Fourth  Framework  Programme  for  Research  and  Technical 
Development ( 1994-1998), research on drug demand reduction has been conducted 
42 mainly under the Biomed 2 Programme. Under Area 3 Brain Research, three projects 
have been financed to study brain receptors and the physical mechanisms of  pain and 
drug addiction.  One additional project has been financed  in the  field  of doping in 
sports, concerning the use by athletes of  growth hormones. 
Also  in  the  context  of the  Fourth  Framework  Programme  for  Research  and 
Technological Development research was conducted in the following areas: 
- social costs  and cost effectiveness:  the  programme on Targeted  Socio-Economic 
Research provided the possibility of financing  the development of methodological 
tools for analysing data such as social costs and cost-effectiveness of  policies, analysis 
of  different policy scenarios and the setting up of  networks of  scientists from different 
disciplines  to  develop  socio-economic  analyses  of drug  use,  consequences  and 
interventions. 
- roadside testing:  two research projects on roadside drug testing (entitled ROSITA 
and CERTIFIED) were initiated. Rosita concentrates on state-of -the art equipment 
for testing the presence of  drugs and medicines in urine, saliva and sweat, as well as 
operational, legal, institutional and user requirements.  CERTIFIED will concentrate 
on psychophysiological  (perceptual  and motor skills) detection methods  for  drugs. 
These projects will run into 2000. 
In the context of  COST (European co-operation in the field of  scientific and technical 
research) an action on "the evaluation of  action against drug abuse" was set up in 1992 
which produced its evaluation report in August 1998. Also financed in the framework 
of  COST, a study on "Quality and ethical aspects of interventions against drug abuse 
in Europe" has recently started. 
Further  to  a joint initiative  with the  Dutch  and  Luxembourg  Presidencies  of the 
Council, a High level Workshop on Priorities for Research in the field of synthetic 
drugs took place in  Brussels on 16  September 1997  which identified the research 
priorities in the field. 
Research on drug related issues has received specific attention in the Fifth Framework 
Programme  for  research,  technological  development  and  demonstration  activities 
(1998 to 2002), in particular in the programme "Quality of live and management of 
living  resources".  The  priority  areas  are  indicated  in  chapter IV.B.3  of the  main 
document. 
43 2.5  Granting of  aid to growers of  hemp 
In June 1998 the Council adopted Regulation (EC) no  1420/98
28 amending Regulation 
(EC) n°  619171  laying down general rules for the granting of aid to  growers of flax 
and hemp.  The amendment limits the granting of aid to  any hemp grower who  has 
concluded a contract with an approved primary processor of hemp or who processes 
hemp  into  straw.  The  aid  will  only  be  granted  if  the  weight  of  THC 
(tetrahydrocannabinol) in the weight of a sample maintained at constant weight is no 
more than: 
- 0.3% for the purposes of  the grant of  aid until the 2000/2001 marketing year 
- 0.2% for the purposes of  the grant of  aid for subsequent marketing years. 
Ill.  ACTION ON REDUCTION OF ILICIT TRAFFICKING IN NARCOTIC 
DRUGS AND PSYCHOTROPIC SUBSTANCES 
3.1  Diversion of  precursors and psychotropic substances 
In  the  field  of precursor  control  the  Community  is  responsible  for  proposing 
legislation  and  policy.  Member  States  are  responsible  for  implementing  both 
legislation and policy. 
In  the  field  of  intra-Community  surveillance,  Directive  92/1 09/EEC  of  14 
December  1992  on  the  manufacture  and  the  placing  on  the  market  of certain 
substances  used  in  the  illicit  manufacture  of narcotic  drugs  and  psychotropic 
substances  constitutes  the  legislative  framework  which  is  implemented  by  the 
Member States.  Close contacts are maintained with the  chemical trade associations 
with a view to  improving the necessary co-operation in the  sharing of information 
concerning  the  diversion  of the  chemical  precursors  listed  under  Annex  1 of the 
Directive. 
This  co-operation  mechanism  between  the  trade  associations  and  the  competent 
authorities of the  Member States could be  extended to  substances not  listed  under 
Annex 1 of  the Directive when the amendment to the existing legislation is adopted in 
1999 to cover precursors to new synthetic drugs. 
29 
In  the  field  of control on  the external trade of chemicals, the  Community legal 
instruments  are:  Council  Regulation 3677/90  and  Commission  Regulation 3769/92 
along  with  a  number  of precursor  control  agreements  which  the  Community  has 
concluded on a bilateral basis with eight countries of the Organisation of American 
States (OAS).  Furthermore,  on the basis of these agreements, the Community may 
provide technical  assistance  in  chemical  control  to  the  Andean  countries  (Bolivia, 
Colombia, Ecuador, Peru, Venezuela), Chile and Mexico. 
Regular meetings at expert level take place between the Commission and the Member 
States  in  the  context  of the  drug  precursors  committee  under  Article  10  of 
21 OJ n° L 190 of  4 July 1998 
29 Proposal for a European Parliament and Council Directive amending Council Directive 92/109/EEC 
(COM(1998) 22 fmal of21.01.98) 
44 Regulation 3677/90 and Directive 92/109/EEC. These meetings allow the discussion 
of Community precursor legislation and its implementation by the Member States. It 
is  in  this  forum  that  an  evaluation of Community precursor control  instruments  is 
made. No external evaluation has been made of the effectiveness of  such Community 
instruments. 
A Council  mandate  provided  in  September 1995  the  basis  for  the  Commission  to 
negotiate bilateral precursor control agreements with the OAS countries. The relevant 
negotiations led to the conclusion of eight agreements with:  a) the Andean countries 
(Bolivia,  Colombia,  Ecuador,  Peru,  Venezuela)  in  December  1995;  b)  Mexico  in 
March 1997; c) the US in May 1997; d) Chile in November 1998. Negotiations have 
taken place with the MERCOSUR countries. 
In  September 1993  a  Council  mandate  provided  the  basis  for  the  Commission  to 
negotiate precursor control  agreements  with  the  ASEAN  countries.  Discussions  at 
service level have taken place with Indonesia, Malaysia, the Philippines and Thailand. 
At United Nations level, the Community has actively contributed to  several meeting 
and international·negotiations on precursor control. These concerned inter alia: a) the 
UNGASS-drugs negotiation sessions for the Action Plan on precursors in  1997 and 
1998;  b) the  annual  sessions of the  Commission  on  Narcotic  Drugs  (CND)  where 
precursor control issues were  addressed;  c) a number of seminars convened by the 
International Narcotics Control Board (INCB) on precursor control; d) the meetings of 
the  Heads  of National  Drugs  Law  Enforcement  Agencies-Europe  (HONLEA)  as 
organised by the United Nations Drug Control Programme (UNDCP). 
The Commission and US-DEA jointly organised a number of meetings gathering the 
largest precursor producing and trading nations have been organised in order to draw 
up  common  guidelines  for  the  informal  and  voluntary  exchange  of information 
(Multilateral Chemical Reporting Initiative). The most recent meetings were held in 
Prague (February 1997) and Lisbon (November 1997). 
In  1994-1997,  the  Commission  organised  training  seminars  since  1994  aimed  at 
getting officials  in  the  Member States better acquainted with precursor control.  In 
1997, those seminars were also conducted at national level. 
In  1994, the Commission created PREXCO as a valuable database on precursors to 
help Member States set up the appropriate legislative structures on precursor control, 
as this very technical activity was brand new for many Member States. After the entry 
into force ofRegulation 515/97
30
,  PREXCO became no longer a useful tool; however, 
PREXCO  data  will  be  maintained  in  the  Customs  Information  System  (CIS)  for 
access to relevant authorities in the Member States. 
30 This created the legal base for the Customs Information System: a central Community data-base 
allowing administrative authorities in the Member States to investigate and prosecute offences in 
customs and agricultural matters, including precursors. 
45 3.2  Money laundering 
The Commission's Second Implementation Report adopted on 1 July 1998 concerning 
the Directive on the prevention of the use of the financial system for the purpose of 
money laundering
31  has been forwarded to the Council and Parliament. It records that 
all the Member States have implemented the Directive. The one current infringement 
procedure  concerns  Austria's  anonymous  savings  books.  The report  also  makes  a 
fairly positive assessment of the impact of the Directive. However, an important aim 
of  the Directive is preventive in nature and it is impossible to assess how much money 
laundering  may  have  been  prevented.  On  the  other  hand  the  data  on  suspicious 
transaction reports  shows that the  financial  sector has  responded  fairly  well  to  its 
responsibilities under the Directive. 
Enhanced  measures  need  however  to  be  taken  as  requested  by  the  European 
Parliament  and  by  the  Organised  Crime  Action  Plan.  Steps  are  being  taken  m 
particular to widen the scope of  the Directive to non-financial sectors. 
3.3  Judicial,  customs  and  police  co-operation  under Title  VI  of the  Treaty  on 
European Union (TEU) 
Since the entry into force of the Treaty on European Union, the co-operation in the 
fight  against  illicit drug trafficking has  led  to  the adoption by the  Member States 
under Title VI  of the  TEU of a great number of legal  instruments.  These  include 
Programmes related to the training and exchange of  law enforcement personnel. Since 
the  adoption  of the  EU  Action  Plan  to  Combat  Organised  Crime  many  concrete 
measures referred to in the Action Plan's recommendations are being implemented. 
The impact of Title VI  legal instruments have not yet been evaluated.  Indeed these 
legal instruments and programmes have been recently adopted and implemented The 
Commission intends in future to contribute to the monitoring of  the implementation of 
Title  VI  instruments  and  Programmes.  External  evaluation  of  the  Title  VI 
Programmes will be carried out in 1999. 
3.3 .1  General frameworks for co-operation. 
•  ruDICIAL CO-OPERA  TON : 
Extradition 
Member States'  extradition  arrangements  are  guided by a number of international 
agreements, in particular the European Convention of 1957 relating to Extradition. To 
facilitate  and  improve  these  arrangements,  the  EU  Convention  on  simplified 
extradition  was  adopted  in  1995
32  followed  by  a  more  general  convention  on 
extradition in  1996
33 
.. The 1996 Convention provides for the extradition of nationals 
and although Member States are permitted to derogate by way of declaration to this 
31  OJ N° 166 of28.06.91 
31 OJ N° C 78 of30.03.95. 
33 OJ N° C 313 of  23.10.96 
46 rule,  such  declarations  are  time-limited  and  subject  to  revtew.  However  this 
Convention has not yet entered into force. 
Mutual legal assistance 
Mutual Legal assistance between Member States is mainly provided through the 1959 
European Convention on Mutual  Assistance.  Work is  currently ongoing on a  new 
Convention  and  Protocol  to  further  facilitate  and  improve  the  mutual  assistance 
provisions of  the 1959 Convention between Member States. The new Convention will 
provide  for  direct  contact  between judicial  authorities  and  includes .  a  number  of 
provisions  to  meet  the  needs  of modem means of investigation  and prosecution, 
including  the  use  of controlled  deliveries,  interception of telecommunications  and 
video  link.  Further work will be pursued on the use of other special  investigative 
measures in the context of  a later protocol to the Convention. 
European judicial network 
The EU Joint Action of  29 June 1998 on the creation of  a European Judicial Network 
provides a framework for contact and exchange of  experience between magistrates to 
improve judicial co-operation between the Member States.
34  The network came into 
existence in 1998 and has now established contact points in each Member States. The 
network  provides  a  forum  for  periodic  meetings of the  contact  points  as  well  as 
providing for up to date information. The contact points are available to the judicial 
authorities in their own country and in other states to assist in judicial co-operation 
requests. 
•  POLICE AND CUSTOMS CO-OPERATION 
The global framework for co-operation in police matters has been dominated by the 
adoption of the Convention of 26 July  1995  on the establishment of a European 
Pollee Office (Europol) which entered into force on 1 October 1998.
35  Also of  major 
importance is the adoption of the Joint Action of 14  October 1996 providing for a 
common framework of the initiatives of the Member States of the EU concerning 
liaison  officers.
36  The general  framework  for police co-operation is also  enhanced 
through  the  creation  and  maintenance of a directory  of specialised  competence, 
skills ·and expertise in the fight against internadonal organised crime, in order to 
facilitate law enforcement co-operation between the Member States. 
37 
Close working relationship between police forces and customs services and definition 
of  their respective roles in the context of  drug law enforcement activities with a view 
to  enabling  them  to  work  together  more  efficiently  and  effectively  has  been  the 
subject of a Council Resolution on police/customs agreements in the fight against 
drugs on 29 November 1996
38
• 
34 OJ N° L 191 of7.07.98 
35 OJ N° C 316 of27.11.95 
36 OJ N° L 62 of20.03.95 
37 OJ N° L 342/2 of31.12.96 
38 OJ N° C 375 of  12.12.96 
47 Additionally the Council  Joint  Action of 9  June  1997  concerning the  refining of 
targeting criteria, selection  methods,  etc.,  and  collection of customs  and  police 
infonnation aims at optimising the use of targeting criteria and structured selection 
methods, and at the collection of  customs and police infonnation on the combating of 
drug traflicking
39
• 
•  DRUGS 
The  Joint  Action  of  the  Council  of  17  December  1996  concerning  the 
approximation of the laws and practices ofthe Member States ofthe EU to combat 
drug addiction and to prevent and combat illegal drug traflicking
40 aims at enhancing 
co-operation in the fight against drug addiction and at the approximation of  national 
legislation "to make them mutua?ly compatible to the extent necessary to prevent and 
combat illegal drug trafficking in the Union".  Member States also need to endeavour 
to make the practices of their police, customs services and judicial authorities more 
compatible with each other and ensure that under their legal systems the penalties 
imposed for serious drug trafficking are among the most severe penalties available 
for crimes of  comparable gravity. 
In  this  latter  area,  the  Council  adopted  on  20  December  1996  a  Resolution  on 
Sentencing for Serious Illicit Drug Trafficking
41  which  confinns  that  Member 
States should ensure that their national laws provide for the possibility of custodial 
sentences for serious illicit drug trafficking which are within "the range of  the most 
severe custodial penalties imposed by their respective criminal law for crimes of 
comparable gravity". 
In many cases, successes in the fight against drugs trafficking implied a high level of 
co-operation between law enforcement services and business organisation. In order to 
consolidate the already co-operative relationship between customs authorities and the 
business organisations the Council adopted a Joint Action on 29 November 1996 on 
co-operation
42  which  calls  on  Member  States  to  establish  or  further  develop 
Memoranda  of  Understanding  between  customs  authorities  and  business 
organisations. 
The Council has decided to set up a  mechanism for the exchange of infonnation on 
the  chemic~l profiling of drugs through the adoption of the  Joint  Action of 29 
November 1996
43
•  The Drugs Unit of  Europol has been designated as the authority to 
which  infonnation  from  Member  States  concerning  chemical  profiling  is  to  be 
transmitted. 
On 16 June 1997, the Council adopted the Joint Action concerning the infonnation 
exchange, risk assessment and the control of new synthetic drugs
44-which aims at 
the setting up of  an early warning system for new synthetic drugs linking the Member 
States, Europol, the EMCDDA and the European Commission. Up to now two new 
39 OJ N° L 159 of 17.06.97 
40 OJ N° L 342/6 of31.12.96 
41  OJ N° C 10 of 11.01.97 
41 OJ N° L 322 of 12.12.96 
43 OJ N° L 322 of 12.12.96 
44 OJ N° L 167 of25.06.97 
48 synthetic drugs have been the subject of the early warning system, MBDB  and 4-
MT  A. It is necessary to use to the full this new instrument before deciding if  a more 
pro-active instrument would do better. 
3.3.2  Programmes under Title VI of  the TEU 
OISIN 
The OISIN programme has been established in the framework of  the EU by the Joint 
Action of20.12.1996
45
• It provides a framework to develop and enhance co-operation 
between police, customs and other law  enforcement authorities
46 of Member States 
and to provide such authorities with a greater insight into the working methods of 
their counterparts in other Member States. 
A  large number of the projects supported by OISIN have been related to  the fight 
against drug trafficking which has been repeatedly at the top of  the priority actions as 
enumerated by the annual working programme ofOISIN. 
The expected results are to make law enforcement authorities better acquainted with 
the working methods of  their counterparts throughout the European Union. 
To meet these aspirations, the following actions are supported: 
- provision of  training, 
- exchange of  personnel and provision of  operational expertise, 
- research, operational studies and evaluation, 
-operational projects (including, briefings and debriefing meetings), 
- information exchange. 
It is worth noting that special attention will continue to be given to projects open to 
candidate  countries,  in  accordance  with  the  Commission's Agenda  2000  and  with 
Article 7 § 4 of the Council Joint Action establishing this programme, that states that 
''the projects may involve those responsible in the applicant countries with a view to 
making them familiar with the achievement of the European Union in this area and 
contributing to  their preparation for  accession,  or in other third countries where  it 
serves the aims of  the projects." 
FALCONE 
On  19 March  1998  the  Council  of the  European  Union  adopted  the  multiannual 
Falcone programme of exchanges, training and co-operation for persons responsible 
for  action  to  combat  organised  crime
47
•  This  programme  focuses  on  activities 
contributing  to  the  implementation  and  monitoring of tlle  Action  Plan to  combat 
organised crime, adopted by the Council on 28 April 1997. 
The  Falcone  programme  is  intended,  through  a  multidisciplinary  approach  to 
prevention and enforcement, to support projects of  benefit to the European Union and 
45 OJ N° L 007 of 10.01.97 
46 
- For the purpose of  this programme, "law enforcement authorities" means all public bodies existing in Member States which 
II'C responsible under national law for preventing, detecting and combating criminal offences. 
47 OJ N° 099 of31.03.98 
49 involving participants from more than one Member State. In particular it will support 
training  measures  and  exchanges,  joint projects  to  improve  skills  and  operational 
methods in co-operation in the fight against organised crime, research and studies and 
other ways  of improving  skills,  with  the  aim  of strengthening  and  facilitating  the 
struggle  against  organised  crime  and  reducing  such  obstacles  as  may  exist  to  co-
operation between the Member States. 
These measures are directed towards those responsible for the fight against organised 
crime,  namely  judges,  public  prosecutors,  police  and  customs  departments,  civil 
servants, public tax authorities, authorities responsible for the supervision of  financial 
establishments  and  public  procurement,  including  the  fight  against  fraud  and 
corruption,  and  representatives of professional  circles who  may be involved  in the 
implementation of some of the recommendations in the Action Plan, as well as the 
academic  and  scientific  world.  The  projects  may  involve  those  responsible  in  the 
applicant countries,  with  a view to  helping them prepare  for  accession,  or in  other 
non- member countries where it serves the aims of  the projects. 
Co-operation  projects  on  drugs  to  be  financed  under  the  FALCONE  programme 
should concentrate on the multidisciplinary approaches to be developed to prevent and 
fight the activities of  the criminal organisations involved. 
GROTIUS 
The Grotius Programme was established by a joint Action of 28  October 1996
48  and 
provides  incentives  and  exchanges  for  legal  practitioners  in order to  foster  mutual 
knowledge of  legal and judicial systems and to facilitate judicial co-operation between 
Member States.  The programme  establishes  a framework  for  training,  information, 
study and exchange programmes for legal practitioners. 
3.4  Schengen activities in the field of  illicit drugs 
The Schengen Member States have carried out different compensatory measures and 
co-operation. Particularly important have been the activities of  the Schengen Narcotic 
Drugs working group, whose initiatives and proposals have obtained good results in 
the  fight  against  illicit  drugs.  The  measures  aimed  at  improving  external  border 
controls and the extension of  cross-border co-operation with a view to combating drug 
trafficking deserve  special  attention  in  the  framework  of Schengen.  Equally,  the 
strengthening of the  direct  and  practical  co-operation between police and  customs 
authorities  and  those  measures  aimed  at  facilitating  judicial  assistance  and  co-
operation between judicial authorities should be emphasised. 
In  the  area of drug demantl control, the  measures  adopted to  monitor cross-border 
traffic in legal drugs as contained in the Schengen Convention should be mentioned. 
In 1993 the setting up of a certificate for crossing the border with drugs required for 
medical treatment was approved. In 1998, the list of  competent authorities for issuing 
or authenticating this certificate was updated. 
41 OJ 0° L 287 of  8. I 1.96 
50 IV.  ACTION AT INTERNATIONAL LEVEL 
4.1  North-South Context 
- The various instruments and  programmes 
The implementation of the CFSP, the growing awareness of the drugs threat and the 
1995-1999 EU Action Plan have led to a very much enhanced EU activity in the fight 
against  drugs  both  in  international  fora  and  in  relation  with  third  countries  and 
regtons. 
With increased recognition of shared responsibility as a cornerstone for international 
co-operation in the fight against drugs,  specific clauses have been introduced in EU 
agreements with third countries and regions.  In the context of CFSP, drugs  issues 
have  become  a  prominent  subject  in  the  EU's political  dialogue  with  numerous 
countries and regions. This is already the case in the EU's relations with the CEECs, 
Cyprus,  Russia and  other NIS,  the  USA,  the  Andean,  Central  American  and  Rio 
Group countries,  the Caribbean,  West African and  Southern Africa regions,  and  is 
gaining  importance  in  ASEM  meetings  as  well.  In  1998,  the  EU  adopted  a 
Co-operation mechanism with Latin American and Caribbean countries whose first 
meeting has taken place in April 1999. CFSP actions to press for specific results, e.g. 
by demarches, have however been relatively rare. 
Both bilateral and multilateral fora are witness to the respect and interest raised by the 
Community's balanced  and  solid  approach  to  drug  fighting.  The  recent  financing 
agreement signed by the  Community and the  Andean Community,  a  result of the 
ongoing  dialogue  between  both  regions,  provides  further  evidence  of what  the 
Community can achieve through its positive measures and dialogue with beneficiary 
countries  in  the  field  of harmonisation  of  legislation,  money  laundering  and 
precursors,  rather than through the application of unilateral  measures.  A  European 
Council  initiative  and  Community  support  has  allowed  the  development  and 
implementation of a coherent and concerted Action Plan in the Caribbean region. In 
1999,  the  EU adopted  a  comprehensive  Action Plan for  Latin  America,  including 
inter-regional co-operation with the Caribbean. 
Trade policy comprises a special 'Drugs regime' granted under the EC GSP scheme to 
the Andean and Central American countries granting free access to the EU market for 
most exports of  interest to these countries.  The scheme provides significant room for 
the  diversification  of the  beneficiary  economies  away  from  drug  production  and 
towards alternative sources of employment and income.  The preferences, originally 
granted in the early  1990s, have been renewed on the commitment by beneficiary 
countries  that  they  will  continue  implementing  policies  conducive  to  both  drug 
eradication and sustainable development. Based on a evaluation of  the GSP impact on 
combating  drugs,  the  agricultural  EU  GSP  scheme  to  the  Andean  and  Central 
American countries was extended until 31  December 2001  and the industrial one was 
also granted for the first time to Central America. Recent ministerial meetings with 
both the Central American Andean countries have confirmed the political usefulness 
of  the scheme and the high value attached to this instrument by beneficiary countries. 
51 - The budget lines 
There is considerable financing of  drug control projects in developing countries. This 
is the case with regard to the ACP, and thanks to the budget line for  financial  and 
technical  co-operation  with  Latin  America,  as  is  the  case  of a  major project  for 
alternative  development  in  Bolivia  (Chapare)  and  Peru  (Pozuzo-Palcazu)  and 
Colombia, as well as of  a regional capacity building programme in Southern Africa. 
A further important instrument for financing drug projects in developing countries has 
been the Community's budget line for North-South co-operation in the fight against 
drugs.  The  limited  funds  available  under  this  budget  line  and  the  wide  range  of 
requests for  funds  has led to choosing projects that are relatively small and have a 
catalytic/pilot role and effect. The Mediterranean, the Latin American, the Asian and 
ACP countries can each count on a little more than 2 Mio ECU per year from  the 
North/South budget line. 
The  funds  used  over  the  years  have  gone  to  institution  building  (Master  Plan 
development), demand reduction efforts,  and supply reduction activities.  Regarding 
demand  reduction,  most  efforts  have  been  channelled  through  NGOs  and  have 
covered the prevention-treatment-rehabilitation spectrum and will support the creation 
of a  national  observatory  on  drugs  (Venezuela).  Supply  reduction  efforts  are 
generally  geared  towards  the  prevention  of  money  laundering  and  chemical 
precursor's diversion,  rather than  to  law-enforcement measures  defined  in  a  strict 
sense. 
- Assessment 
Any indication of  success in the EC external efforts at drug fighting must be measured 
by a two-tiered yardstick.  Firstly, the intensity of  the challenge which, in this case, it 
must be recognised,  is  particularly overwhelming.  Secondly, the means placed at 
disposal, which are generous in terms of  trade policy, yet limited as regards financial 
resources.  Furthermore, the evaluation of  success must recognise that EC action can 
only act as a complement to and,  in the best of cases, as a catalyst for beneficiary 
countries' actions.  From this triple perspective it can be argued that EC efforts have 
met with considerable success. 
4.2  Phare Multi-Beneficiary Drugs Programme 
The programme had the following impact in the region: 
- In the field of policy development:  the programme (a) increased the awareness of 
drug issues in the CEECs, and promoted the development of multi-disciplinary and 
co-ordinated drug policies, (b) increased the capacity in the countries concerned to 
develop  drug  information  systems  and  strategies,  along  the  methodology  of the 
EMCDDA, and (c) provided a more accurate picture of the situation in the CEECs; 
the measures taken by them and of  their priorities for assistance in the field of  drugs. 
-In the field of  drug demand reduction~ the programme (a) promoted the importance 
of drug demand reduction in order to ensure a balanced approach in the CEECs, (b) 
52 increased the awareness of  the importance of a multi-sectoral and integrated approach 
in demand reduction, (c) increased the capacities of  professionals in this field. 
- In the field of  drug supply reduction, the programme facilitated the approximation of 
legislation and standards in field of  precursors monitoring and money laundering. 
An external evaluation took place in 1996 of  the drug demand reduction pilot project, 
which provided recommendations to  define the  follow-up phase of this project.  In 
1997, an external assessment took place by the Office for Monitoring and Assessment 
(OMAS) of the overall 1992 and 1993  programmes. This assessment acknowledged 
the large amount of  activities implemented by the programme.  However, it concluded 
that 'the programmes have yet not achieved the desired objectives' mainly due to the 
fact that the programmes set up  unclear or unrealistic objectives. It also pointed out 
the fact that programmes seem to focus more on the development of  projects, than on 
the achievement of  clear drug control objectives. The results of  an external evaluation 
ofthe 1996/1997 programmes are envisaged to be available by the end of 1999. 
4.3  The European Conference Experts Group on Drugs/Organised Crime 
In the framework of the European Conference, an Experts Group was set up  whose 
objective was, by means of cross-border co-operation, to combat jointly corruption, 
organised crime, illegal trafficking and money laundering in Europe. On the basis of 
its work, the German Presidency of the Council prepared a set of recommendations 
which refer in particular to  the  need  for  the  EU Drug Action Plan (2000-2004) to 
make provisions for appropriate resources intended for measures to combat drugs in 
Central and Eastern Europe and Central Asia. 
4.4  Relations with industrialised countries 
In our relations with our industrialised partners co-operation on drugs has focused on 
the  exchange  of data  as  well  as  upon  co-operation  on  different  programmes  for 
regions most affected by drug related problems. Both at bilateral and at multilateral 
level drug trafficking has been recognised as  an important area of co-operation, one 
meriting further development and strengthening. 
•  USA 
The  most  significant  co-operation  has  developed  with  the  US.  Under  the  New 
Transatlantic  Agenda  (NTA)  the  EU-US  co-operation  on  counter-narcotics  has 
intensified over the last years. Within this framework, a bilateral agreement between 
the US and EU on controlling chemical drug precursors was concluded in the Hague, 
on May 1997. Another outcome of EUIUS co-operation under the NT A is the jointly 
financed  regional  money  laundering  programme  and  maritime  co-operation  in  the 
framework  of the  Barbados  Action  Plan.  The  EU  Caribbean  Drugs  Initiative  has 
contributed  significantly to  the  improved  co-operation  to  counter drug  trafficking, 
money laundering and organised crime in the  region.  The Parties have pledged to 
continue and develop the existing co-operation in the Caribbean and, where possible, 
to  extend  it  to  other regions,  such  as  Latin  America,  Africa and  Central  Asia.  In 
addition,  the  EUIUS  relationship  consisted of close co-operation  between  US  and 
European  law  enforcement  agencies  and  the  participation  of the  US  in  the  EU 
53 multidisciplinary  Group  on  Organised  Crime.  Both  actions  will  continue  in  the 
upcommg years. 
•  Canada 
Among the undertakings of  the parties in the EU-Canada Joint Action Plan, signed on 
17  December  1996,  were  co-operation  to  enhance  the  effectiveness  of the  Dublin 
Group as the informal forum for co-ordination of international assistance in the fight 
against  drugs,  to  endeavour  to  reach  an  agreement  on  the  diversion  of precursor 
chemicals  and  to  co-operate  in  the  counter-narcotics  assistance  projects  in  the 
Caribbean and in other regions of  the world (Africa). Discussions on the possibility of 
concluding  a  precursor  agreement  with  Canada  took  place  during  1997,  but  an 
agreement has not yet been concluded. 
•  Japan 
During the  EU-Japan Ministerial Meeting, in October 1998, it  was recognised that . 
efforts should be made to encourage exchange of  experience and information between 
the  two  partners.  Former Japanese Prime  Minister has  set up  a Committee for  the 
promotion of  measures to prevent drug abuse. This Committee has announced a five--
year strategy for  the prevention of drug abuse, which will help to  set guidelines for 
medium term measures in this area. Intentions were expressed on the occasion of  the 
EU-Japan Summits,  to  set  up  a dialogue  in this  field,  which could develop  into  a 
regular exchange of information within an expert group.  This has been stressed in 
particular  at  the  Asian  Drug  Law  Enforcement  Conference  organised  by  the 
Government of Japan  in February 1999 with the  participation of representatives of 
Cambodia,  China,  Laos,  Burma,  Thailand,  Vietnam,  UNDCP,  the  USA  and  the 
European Commission. 
•  G8 
At the multilateral level, in the Birmingham Summit of May 1998,  the G8 Heads of 
State welcomed the UNGASS on drugs and reiterated their commitment to develop a 
comprehensive strategy to tackle all aspects of  the drugs problem. The G8 reaffirmed 
their  commitment  to  partnership  and  shared  responsibility  in  the  international 
community to  combat illicit drugs,  including reinforced co-operation to  curb  illicit 
trafficking  in  drugs  and  chemical  precursors,  action  to  reduce  demand  in  the  G8 
countries,  including  policies  to  reduce  drug  dependency  and  support  for  a  global 
approach to eradicate illicit crops. The G8 welcomed the UNDCP's recent initiatives, 
which imply the preparation of  alternative and reliable development programmes and 
benchmarks within existing funding arrangements. 
•  China 
The  Commission's  Communication,  "Building  a  Comprehensive  Dialogue  with 
China", of  March 1998, underlines the necessity to promote a substantial dialogue and 
encourage co-operation with China on various issues including combating illegal drug 
trafficking. 
54 V.  GLOBAL ASSESSMENT 
The following global assessment can be made: 
- Internal policies 
The drugs policies applied so far have not succeeded in eradicating the drugs problem 
itself. Crime connected with drug trafficking and offences related to  secure personal 
supplies  of drugs  still  constitute  a  serious  problem  throughout  the  EU.  Enhanced 
application of law enforcement measures has led to the overcrowding of prisons with 
drug-related offenders.  The  response of the  EU  Member States has  been to  devote 
increasing efforts and resources to prevention policies. The spread of  AIDS has played 
a major part in the development of projects designed to  reduce the risks associated 
with the consumption of injected drugs. These prevention policies have proved to be 
efficient.  It is  necessary to  stress that major reduction of financial  commitment by 
Member  States  to  social  sector  activities  could  undermine  the  balanced  approach 
between supply and demand reduction. 
In the field of  criminal justice, Member States have been trying for several years now 
to integrate within the law enforcement system certain measures particularly aimed at 
demand  reduction.  The  range  of action  of the  criminal  justice  system  (police, 
prosecution,  courts  and  penitentiary system)  is  indeed  no  longer  limited  to  purely 
repressive  measures.  The  majority  of Member  States  have  established  structures 
aimed at informing and counselling persons convicted of a drug offence. All Member 
States have provisions to propose under certain circumstances alternatives to a prison 
sentence  for  drug-related  convicted  persons.  The  comparison  between  the 
effectiveness  of compulsory  and  voluntary  treatment  is  the  subject  of evaluation 
studies but is still the subject of  divergent opinions. 
- External policies 
With regard to international drugs control co-operation, the EU has made significant 
progress. Co-ordination of  drugs control at policy level, as well as of  co-ordination of 
activities  has  improved  but  should  be  further  enhanced.  Jointly  launched  EU 
initiatives have  laid  the  groundwork  for  closer co-operation within the  EU  and  in 
relation to  third countries. These new political initiatives resulted in the elaboration 
and adoption of  commonly agreed Action Plans for the Caribbean, Latin America and 
Southern  Africa.  The  Action  Plans have provided useful  instruments,  enabling  an 
improved co-ordination while ensuring complementarity of operational activities and 
thereby avoiding duplication and overlapping of  individual donor assistance. 
55 Annex II 
CURRENT TRENDS IN DRUG DEMAND REDUCTION 
On the basis of  information collected by the EMCDDA, it can be stated that: 
a) there is a general trend towards diversification in the prevention field, employing 
a  two-pronged  strategy  - broad  education  and  health  promotion  targeting  the 
general population- supplemented by specific actions targeting vulnerable. and at-
risk groups; 
b)  support  for  drug  users  in  Europe  has  increasingly  taken  the  form  of 
differentiated services oriented towards the individual, while seeking simultaneous 
co-ordination of  existing services and the improvement of  co-operative structures. 
In the prevention field  there has been an increased emphasis on initiating education 
programmes  at  an  early age  as  a  means of establishing protective  factors  against 
subsequent drug use.  However,  comprehensive community prevention programmes 
remain rare in Europe. Evaluation results in Europe provide evidence that improved 
interpersonal relationships, autonomy and resistance to peer pressure as being critical 
protective factors. 
In this context, peer projects have  shown their utility  as  a means of incorporating 
primary prevention within the leisure time activities of  young people. 
Although there has been little evaluation of mass media campaigns, some evidence 
suggests that these may have the effect of  raising awareness. 
The  Internet  is  increasingly  used  for  dissemination  of information.  In  this  the 
EMCDDA plays a crucial role by offering Internet based services to programmes and 
practitioners in the field of  evaluation and mutual exchange of  experience. 
Early intervention and at-risk groups: Throughout the EU there is an increasing harm 
reduction focus on groups experimenting with ecstasy and other drugs in the dance 
scene.  This seems to  be a particularly European approach, which permits the rapid 
development  of further  special  intervention  techniques  for  dance  culture  settings. 
Specific measures have included guidelines on 'safe raves', including free drinking 
water,  rest  areas,  information  and  counselling,  as  well  as  the  initiation of on-site 
testing facilities. 
Outreach strategies, as well as targeted self-help and peer group work, have accessed 
'at risk'  and  marginalised  groups,  often  in  the  context  of natural  social  support 
networks. 
Such  strategies  achieved  encouraging  results  both  for  changing  health  and  risk 
behaviours,  in  the  context  of a  harm  reduction  strategy,  and  in  reaching  groups 
experimenting with drugs at an early stage. 
56 Prevention  of infectious· diseases:  The  decline  in  new  cases  of HIV  has  been. 
accompanied by identification of an alanning rise in Hepatitis C among Intravenous 
Drug Users. Hann reduction measures have played an important role in combating the 
spread of  HIV. A range of strategies - from  maintenance. prescription of substitute 
medication such as methadone, syringe and needle exchange schemes, easily accessed 
('low threshold') services, and education and information campaigns-have combined 
to make a positive impact in a number of  EU countries. However, there is no evidence 
of  an impact on Hepatitis C transmission or changes in the sexual behaviours of  drug 
users with respect to the transmission of  HIV infection. Tuberculosis infection among 
drug users is also of  concern. 
Substitution  and  treatment .  programmes:  Increases  in  the  availability of substitute 
programmes  in  many  EU  countries  have  been  accompanied  by  the  need  for 
consistency in provision and clear markers for outcome effectiveness. Although the 
efficacy-of methadone in terms of health and social integration is recognised,  the 
expanding practice of  substitution treatment also brings issues of  quality control to the 
fore. 
The limitations of  methadone have led to the exploration of  a number of  alternatives -
. of I,.AAM,  buprenorphine  and  prescribed  heroin.  All  EU countries  recognise  the 
importance  of a  range  of substitution  and  drug-free  outpatient  and  ~idential 
treatment options, tailored to individual needs. There is also widespread. recOgnitioR 
of  the need for effective aftercare, and co-operation between treatment facilities and 
general health and social service providers. 
Criminal Justice Policy: In addition to their traditional role in supply reduction, the 
police are increasingly involved in demand reduction and education, 'and in strategies 
to support community partnership. All EU members provide alternatives to custody 
for drug offenders, based on diversion of  the individual from prison to treatment, or to 
work in the community. 
Specific target groups: A number of countries have recognised the· need for gender-
specific approaches to prevention, while facilities that address the specific treatment 
needs  of women  - motherhood,  sexual  violence  and  prostitution  - are  becoming 
increasingly common throughout Europe. Some countries have attempted to address 
the  needs  of addicts  from  particular  ethnic·  and  cultural  backgrounds.  Finally, 
provision for the care of  children of  users has also become increasingly significant in 
prevention and treatment programmes. 
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CURRENT DEVELOPMENT IN LEGISLATION AND PRACTICES 
A.  Overview of  convergence and differences in drugs legislation and practices in 
the EU Member States 
The complex relationship between drug abuse and criminal attitude and the methods 
of reducing and, possibly, eliminating negative consequences are debated by policy 
makers and scientists with positions which sometimes tend to become polarised. The 
debate also involves a whole series of  different aspects of  the problem such as socio-
economic  factors  (e.g.  illegal  market  production,  trafficking,  organised  crime), 
attitudes and behaviour (e.g. lifestyles), bio-medical effects of  the drugs, cultural and 
political aspects. It is this complexity that makes an objective and clear approach to 
the problem so difficult. 
Since  1995,  conferences  and  seminars  organised jointly  by  the  Commission,  the 
European Parliament and the Presidency of  the Council have identified areas in which 
closer co-operation at  Union level  is  necessary to  enhance the effectiveness of the 
fight against drugs. These meetings have shown that there is a considerable degree of 
harmonisation between national narcotic drugs legislation in the EU as they are all in 
conformity with the UN Conventions on narcotic drugs. Effective transposition of  EC 
legislation on precursor chemicals and  money  laundering also provides a common 
legal framework between the 15 Member States. 
These  findings
49  show  however that  differences  exist  at  the  level  of national  law 
mainly in relation to: 
- the wide range of  sanctions for trafficking and for possession; 
- the approach in relation to drug use; 
-the distinction introduced in some Member States legislation between Cannabis 
and its derivatives on the one side, and on the other side, other drugs (which are 
described in many forms) as far as definition of offences and penalties/sanctions 
for drug use, possession and trafficking are concerned. 
These differences become smaller when considering the convergence existing at the 
level of  practical implementation by the judicial authorities, such as: 
- medical or social measures  are  preferred to  prison sentence,  in particular for 
those drug addicts who wish to undergo treatment; 
- in case of occasional use with no aggravating circumstances, the drug user is 
approached, is invited to refrain in future from taking drugs, receives a fine or is 
subject to administrative sanctions; 
49 Conference on Drugs Policy in Europe (Brussels, 7-8 December 1995) and Follow-up workshop on 
the application of  national drugs legislation (25-26 March 1996). Summary discussions and 
conclusions. Brochure available on Internet (Europa web site of  the EU). 
58 - prison continues to play a repressive role only when important quantities are 
concerned or in the presence of  aggravated circumstances; 
- in the case of  cannabis offences, lower sanctions are applied; 
- illicit trafficking is severely repressed in all Member States; 
- lower penalties are applied in the case of addict-pushers (users supplying drugs 
to finance their own consumption). 
Nevertheless, the considerable degree of  discretion enjoyed by the judicial authorities 
in sentencing policy means that large differences may exist not only between Member 
States but also between regions of  the same Member States. 
Based on the comparative study prepared by the Commission for the joint EC/EP/ 
Presidency conference  and  seminar  in  1995/96,  an  updated  comparative  study  on 
drugs legislation in Europe has been prepared for the Vienna European Council.  In 
future,  the EMCDDA could provide a helpful  contribution to  the updating of this 
work. 
Taking all these elements into consideration, it can be said that there already exists a 
considerable  degree  of legislative  harmonisation  and  that  for  the  moment  more 
harmonisation of  national laws is not a feasible objective, except when there is a need 
to fill some legal vacuum. This was the case for the control of  synthetic drugs where 
the gap has been filled by the adoption of  the Joint Action of 16 June 1997 concerning 
the information exchange, risk assessment and the control of  new synthetic drugs. 
50 
The focus of  the attention should however be more on how to reduce the demand for 
drugs. Greater efforts and allocation of  funds are needed for the prevention, education 
and  rehabilitation  sides  of the  fight  against  drugs  as  there  seems  to  be  some 
misperception by the young of  the risks incurred by drug abuse. 
It is also important to have effective and practical co-operation between the Members 
States' police, judicial and customs authorities. Emphasis should equally be put on the 
implementation of a multidisciplinary and partnership approach to the problem, with 
an active contribution from all the players at national, regional and city levels. 
These conclusions were shared by the Dublin European Council and more recently by 
I 
the European Parliament in its resolution of  6 October 1998 concerning European co-
operation in the framework of the UN General Assembly Special Session on Drugs 
(UNGASS).  Sl 
The situation in the EU Member States is now regularly examined at the level of the 
Council since the adoption of the Joint Action of 17 December 1996 concerning the 
approximation of the laws and practices of the Member States of the EU to combat 
drug addiction and to prevent and combat illegal drug trafficking.  5
2 
50 OJ N° 167 of25.06.97 
51  Report of  Mrs d'Ancona.  Doc. A4-0211/98 
52 OJ N° 342 of31.12.96 
59 This instrument will contribute to the identification of  common trends and differences 
in legislation and practices and will fonn the basis for the promotion of  the exchange 
of  information and best practices. 
B.  Prescription of  drugs to drug addicts 
Some topical drug issues have been widely covered in the media and there is a need to 
present the objective situation in this regard. This concerns, in particular, the specific 
issue of  prescription of  narcotic drugs and particularly ofheroin to drug addicts. 
It is worthwhile remembering that the UN Single Convention on Narcotic Drugs of 
1961, as amended by the 1972 Protocol, recognises that the medical use of narcotic 
drugs  continues to be indispensable  for  the relief of pain  and  suffering  and  that 
adequate provision must be made to ensure the availability of  narcotic drugs for such 
purposes, while also recognising that addiction to narcotic drugs constitutes a serious 
danger for the individual. 
Parties  to  the  1961  Single  Convention  are  required  to  take  such  legislative  and 
administrative  measures  as may be necessary to  limit  exclusively to medical  and 
scientific purposes the production, manufacture, export, import, distribution of, trade 
in, use and possession of narcotic drugs. The international drug control Conventions 
do not contain any definition of the expression ''medical and scientific purposes". 
Since each Party to the Conventions must introduce its own implementing legislation, 
it is possible for States to reach different conclusions as to what legitimate scientific 
and medical purposes are. 
An overview of current practices in the prescription of narcotic drugs in different 
countries shows that such drugs are prescribed to address the long-term problem of 
chronic  drug  addiction  and  to  respond  to a  sharp  increase  in injecting  drug  use. 
Methadone  is  the  most commonly used  substitution  agent  in  opioid  dependence. 
However, buprenorphine (brand name, Subutex) has been studied for many years as a 
potentially useful substitution agent and has been introduced to treat opioid addicts in 
France and more recently in some other Member States, including in the UK and in 
Finland.  Heroin  is prescribed  to  drug  addicts  in  only  a  few  States.  Apart  from 
Switzerland, where the decision was taken by referendum to continue with the heroin 
prescription project after the experimental phase, the UK has already been prescribing 
heroin for years, though on a smaller scale. Prescription of  heroin in the UK is being 
legally restricted  to physicians specially licensed by the Home Secretary  for  that 
purpose. The Netherlands is presently experimenting with heroin prescription under 
strict medical control for chronic addicts. 
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1998 COMMUNITY FUNDING IN THE FIELD OF DRUGS 
BUDGET ITEMS  TYPE OF ACTIONS:u  BUDGET ALLOCATION IN 1998 
Iateraal 
Specific drug related 
items 
BJ-4302: Programme of  16 priority actions to be implemented by the year 2000, grouped under two main  SMECU 
Community Action on  headings: (a) data, research and evaluation and (b) infol'mation, health education and 
the Prevention of  Drug  training. 
Dependence (1996-2000) 
B3-441: EMCDDA  The objective of  the EMCDDA is to contribute to the harmonisation of  drug related  7.6MECU 
data collection at EU level. The REITOX National Focal Points fulfil a key role in the 
implementation of  this networlc. 
" Based on data available in the EC-REITOX database. 
61 Non-Specific drug 
related items 
B3-1001: Socrates  Combating drugs is not one of  the major focus points of  the Socrates Education  ± 0.01 MECU (1  project) 
programme and there is no specific action with this aim but it can be eligible as an 
educational theme at most levels of  education and actions within the programme. 
B3-1010/B-3-1011:  Combating drugs is not one ofthe major focus points ofthe Youth for Europe  B3-1010: ± 0.19 MECU (30 projects) 
Youth for Europe/Euro- programme, but it is eligible within the activities : facilitating youth exchanges,  B3-1011: ± 0.05 MECU (10 projects) 
pean Voluntary Service  encouraging local actions and in particular the access of  disadvantaged young people. 
B3-1 021: Leonardo da  Combating drugs is not one of  the major focus points of  the Leonardo da Vinci  ± 0.3 MECU (3 projects) 
Vinci  vocational training programme but it is eligible within the measures concerning 
combating social exclusion. 
B6-7142: BIO-MED  In the framework of  the Fourth Framework Biomed 2 Programme, five research  1 MECU (estimated 1998 budget on 
projects were funded for a total amount of2.9 MECU. They are related to the  the basis of  a total budget of 
following issues: the development of  a methodology for the detection of  doping with  2.9 MECU for a period of3 years) 
grown hormone, analysis of  mechanisms of  chronic pain in order to develop treatment 
strategies, the dopamine 03 receptor in drug addiction, the opioid system and its role 
in drug addiction, etc. The projects started in 1996 and will be finished at the end of 
1999. 
B2-1422: Employment- In 1998, as a result of  a call for tender in 1997, 230 projects (total budget around  Estimated annual budget for I 998 
INTEGRA  55 MECU) were funded focusing on the reintegration ofmarginalised groups,  15-20MECU 
including addicts, into the working place. The projects run over a period of  3 years 
(1998-2000) 
B5-800: Co-operation in  In 1998, in the field of  JHA, 18 projects related to the issue of  drugs and trafficking 
the field of  Justice and  were funded from OISIN (reinforcement of  the co-operation between law  OISIN: 0.74 MECU 
Home Affairs (OISIN,  enforcement bodies). FALCONE (co-operation against organised crime) funded  FALCONE: 0.36 MECU 
FALCONE, GROTIUS)  6 projects and GROTIUS (strengthening of  co-operation between practitioners ofthe  GROTIUS: 0.031 MECU 
judicial system) funded 1 project. 
62 External 
Specific drug-related 
items  . 
B7-6210: North-South  This budget item allows funding of  drug demand reduction and supply. reductio~  8.9MECU 
Co-operation in the field  projects in developing countries. The 1998 budget was equally divided (about  · 
of  drugs and drug  2 MECU each over the following regions: Central and Latin Ameri~  Asia. the · 
addiction.  Caribbean, Africa and the Mediterranean region (including Magreb and Mashrak).  .. 
About 1 MECU was allocated to the African Region.  . 
B7-5000: PHARE:  In light of  the pre-accession strategy, the 1998 programme aims primarily to facilitate  11  MECU 
Multi-Country  the progressive adoption and implementation of  the EU acquis in the fietd· of  drugs. 
Programme for the fight  Within this context, the priorities are (i) the approximation oflegislation and 
against drugs  measures and the establishment of  the necessary institutional structures; in 
compliance with the EU standards and (ii) the strengthening of  the administrative and 
operational capacities of  the competent authorities to apply the acquis in the field of 
drugs. 
B7-520: TACIS:  General Programme for Customs cO-operation with the NIS (total budget 1998  0.5 MECU (estimation) 
5.8 MECU): some activities are directly related to drugs detection. 
Programme for the construction, equipping and technical assistance at 5 Border  1.34 MECU (estimation) 
Crossings (total budget 11.82 MECU). 
Programme for JHA activities targeted mainly at Drugs and Immigration issues (total  2.6 MECU (estimation) 
budget 3 MECU). 
Non-specific drug 
related budget items 
B7-3100: Financial and  Two projects related to alternative development will be funded: 
technical co-operation  - Colombia: upgrading of  Colombian mapping System of  illicit crops,  8 MECU over 4 years 
with Latin American  - Peru: development alternative program in Pozuzo y Palcazu region.  28 MECU over 6 years 
developing countries 
European Development  The EDF allocated in 1998 a budget of5.41 MECU for drug related projects: 21% of  5.41 MECU 
Fund(EDF)  this budget was spent in the African Region (West Africa. Zambia, Botswana), 79% 
in the Caribbean. 
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